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Summary 
 
In megavoltage photon radiotherapy, accurate knowledge of the absorbed 
dose in the build-up region is essential in the clinical management of skin 
toxicity and superficial target coverage. These build-up doses strongly depend 
on a wide range of treatment parameters and evolve, consequently, in close 
relation with treatment technology. Commercial treatment planning systems 
and multiple dosimetric techniques, however, fail to accurately predict build-
up doses. In this respect, this dissertation investigated the impact of recent 
evolutions in megavoltage photon radiotherapy on the absorbed dose and 
calculation accuracy in the build-up region. 
To that purpose, we first compared and optimized the performance of two 
transmission scanners for radiochromic film dosimetry in the high dose 
gradient of the build-up region. The Nikon Coolscan 9000ED scanner (Nikon 
Co., Tokyo, Japan) was identified as the preferential tool for high-gradient 
dosimetry, mainly due to its high sensitivity resulting in more contrast in the 
digitized image. The main limitation of the Nikon digitizer is its film size 
restriction to 6.2x20 cm². 
Secondly, we focussed on flattening filter-free linear accelerators, which 
currently face swift implementation into clinical practice because of their 
increased dose rate and reduction in head scatter compared to conventional 
  
designs. Our study demonstrated that build-up doses in flattening filter-free 
beams provided by standard linear accelerators slightly exceed build-up doses 
in conventional beams, indicating that the shift of the X-ray spectrum to lower 
energies in flattening filter-free mode is nearly compensated by the reduction 
of electron contamination and head scatter. In literature, the reduction in 
electron contamination in flattening-filter free mode is often anticipated to 
improve build-up calculation accuracy, as treatment planning systems 
generally use simple electron contamination models. For the XVMC code 
implemented in the Monaco treatment planning system however, 
considerable differences between build-up measurements and calculations 
were detected in both flattened and unflattened beams, emphasizing the 
importance of other factors that negatively affect build-up calculation 
accuracy. 
Thirdly, this dissertation investigated the dosimetric impact of patient 
positioning devices, which are increasingly used to ensure set-up accuracy 
while delivering highly conformal dose distributions. The presence of the 
components of the AIO patient positioning device (Orfit Industries, 
Wijnegem, Belgium) was found to cause considerable and clinically relevant 
build-up dose increases. Integration of the device CT data into treatment 
planning allowed to accurately model the most important attenuation effects, 
but failed to accurately predict build-up doses.  
Finally, we investigated the potential of modern volumetric arc techniques 
(VMAT) to intentionally reduce the superficial dose to the hair follicles and 
prevent temporary alopecia in whole brain radiotherapy. Compared to the 
standard opposed fields techniques, VMAT was shown to considerably 
reduce the subcutaneously absorbed dose (20.5% on average), mainly on the 
top and the back of the skull (41.8% on average). Accordingly, the mean hair 
  
loss in the study subjects in a prospective phase II trial was the least 
pronounced on the top and the back of the skull. 
  
  
  
 
 
 
Samenvatting 
 
In radiotherapie met megavoltage fotonenbundels is nauwkeurige kennis van 
de geabsorbeerde dosis in de build-up regio essentieel voor het klinisch 
management van huidtoxiciteit en de dosering van oppervlakkige 
doelvolumes. De dosis in de build-up regio hangt echter sterk af van vele 
behandelingsparameters en varieert bijgevolg met evoluties in de 
behandelingstechnologie. Bovendien slagen meerdere dosimetrische 
technieken en commerciële dosisberekeningsalgoritmen er niet in de build-up 
dosis nauwkeurig te bepalen. In dit proefschrift wordt in dit verband de 
invloed van enkele recente ontwikkelingen in megavoltage fotonen 
radiotherapie op de dosis en de berekeningsaccuraatheid in de build-up regio 
onderzocht. 
Vooreerst werd de prestatie van twee transmissiescanners voor 
radiochrome film dosimetrie in de hoge dosisgradiënt van de build-up regio 
vergeleken en geoptimaliseerd. De Nikon Coolscan 9000ED scanner (Nikon 
Co., Tokyo, Japan) bleek daarbij preferentieel voor dosimetrie in hoge 
dosisgradiënten, vooral door zijn hoge sensitiviteit die resulteert in meer 
contrast in het gedigitalizeerde beeld.  Een belangrijke beperking van deze 
Nikon scanner blijft echter de begrenzing van de filmgrootte tot 6.2x20 cm². 
Een volgende studie richtte zich op lineaire versnellers zonder vlakheidsfilter, 
die op dit moment in de klinische praktijk geimplementeerd worden omwille 
  
van hun verhoogde dosistempo en verlaagde verstrooiing van fotonen vanuit 
de versnellerkop. De build-up dosis in fotonenbundels geproduceerd door 
versnellers zonder vlakheidsfilter was licht hoger dan in conventionele 
bundels. Dit wijst erop dat de verschuiving van het X-stralenspectrum naar 
lagere energiëen in vlakheidsfiltervrije fotonenbundels nagenoeg 
gecompenseerd wordt door de reductie van contaminerende elektronenen en 
fotonverstrooiing vanuit de versnellerkop. In de literatuur wordt vaak 
gesuggereerd dat deze reductie van contaminerende elektronen tot een betere 
nauwkeurigheid van de dosisberekening in de build-up regio kan leiden, 
omdat planningssystemen vaak eenvoudige modellen voor 
elektronencontaminatie gebruiken. Voor de XVMC code geïmplementeerd in 
het Monaco  planningssysteem, stelde onze studie echter belangrijke 
verschillen tussen dosismetingen en berekeningen vast, zowel bij bundels met 
als zonder vlakheidsfilter, wat op de grote invloed wijst van andere factoren 
die de dosisberekeningsnauwkeurigheid in de build-up regio negatief 
beïnvloeden. 
Vervolgens werd ook de impact onderzocht van het AIO systeem voor 
patientpositionering (Orfit Industries, Wijnegem, Belgium). Dergelijke 
systemen worden in toenemende mate gebruikt om een nauwkeurige en 
reproduceerbare postionering van de patient te garanderen bij behandelingen 
met sterk conforme dosisverdelingen. De aanwezigheid van de componenten 
van het positioneringssysteem in de stralingsbundel resulteerde in belangrijke 
en klinisch relevante verstoringen van de build-up dosis. Hoewel het 
integreren van de CT data van het positioneringssysteem tijdens de planning 
toeliet om de belangrijkste attenuatie-effecten te modelleren, kon de build-up 
dosis niet nauwkeurig voorspeld worden. 
Tenslotte onderzochten we ook het potentieel van moderne volumetrisch 
gemoduleerde boogtherapie (VMAT) om de oppervlakkige dosis afgezet in 
  
de haarfollikels bij totale hersenbestraling te verminderen en zo tijdelijke 
alopecie te vermijden. Vergeleken met de conventionele techniek (2 
tegenoverliggende velden), verminderde VMAT de subcutane dosis met 
gemiddeld 20.5%, en met 41.8% op de boven- en achterzijde van de schedel. 
Overeenkomstig bleek in een fase II studie het gemiddelde haarverlies het 
minst uitgesproken op de boven- en achterzijde van de schedel. 
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Introduction, Objectives and Outline 
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1.1. Introduction 
Worldwide, approximately 14 million patients were diagnosed with cancer in 
2012. Annual cancer incidence is predicted to rise to 22 million cases in the 
next two decades and more than half of these patients is expected to require 
external beam radiotherapy (Stewart, 2014; Delaney et al., 2005).  
Clinically, megavoltage photon beams are still the most common 
treatment modality in external beam radiotherapy. One of the most distinct 
features of these beams includes their skin-sparing effect, a gradual build-up 
of dose absorption from the patient surface with depth (figure 1.1). 
 
 
Figure 1.1: The build-up of absorbed dose with depth for a 10 MV photon beam. The 
build-up region and the depth of the dose maximum (dmax) are depicted. Absorbed 
doses are normalized to the absorbed dose at 10 cm depth. 
 
The physical phenomena in the build-up region, however, complicate both 
build-up dose measurements and calculations. As a result, multiple dosimetric 
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techniques and commercially available treatment planning systems (TPS) fail 
to accurately determine build-up doses, affecting the clinical management of 
both skin toxicity and superficial target coverage. Additionally, as build-up 
doses vary with a wide range of treatment parameters, evolutions in 
radiotherapy treatment techniques were shown to greatly impact the absorbed 
dose in the build-up region (FitzGerald et al., 2008; see Section 1.4.). The 
introduction of complex techniques such as intensity modulated radiotherapy 
(IMRT), volumetric arc therapy (VMAT) and the increasing use of patient 
positioning devices (Olch et al., 2014) all affected superficial doses and 
amplified the mentioned difficulties in build-up dose calculations. The 
recently developed technique of prone breast irradiation, for example, 
frequently uses specific patient positioning devices (see Chapter 4). 
In this respect, the research presented in this dissertation investigated some 
aspects of the impact of recent evolutions in megavoltage photon radiotherapy 
on the absorbed dose and calculation accuracy in the build-up region. 
 
1.2. The clinical relevance of the build-up region 
1.2.1. Radiation skin reactions 
Firstly, accurate determination and prediction of build-up doses is essential in 
the clinical management of skin toxicity. Approximately 85% of all patients 
treated with radiotherapy still experience moderate to severe radiation skin 
reactions, originating from different layers within the skin structure (Salvo et 
al., 2010).  
Human skin is a complex organ composed of two structural layers: the 
epidermis and the dermis (figure 1.2).  
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Figure 1.2: Structure of the human skin. Modified from: Marieb and Hoehn, Human 
Anatomy and Physiology, Pearson Education/Benjamin Cummings (2008). 
 
The epidermis is the most superficial layer with a rapid self-renewal capacity. 
Its thickness ranges from 20 to 100 ?m in most body sites, but varies greatly 
with the anatomical region considered, between patients and with age (Farage 
et al., 2007). The outermost epidermal layer primarily consists of dead 
cornified cells that are shed through normal desquamation. These detached 
cells are continuously replaced by mature skin cells originating from an 
underlying single layer of stem cells. This stem cell layer is often referred to 
as the basal cell layer and resides within the outermost 25% of the local 
epidermal thickness (ICRP, 1992). The constant repopulation of the 
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epidermis from this basal cell layer ensures a naturally rapid renewal of all 
epidermal layers every 3 to 4 weeks (FitzGerald et al., 2008). 
The dermis underlies the epidermis and provides all supportive structures 
required for the epidermis to renew (Wells, 2003).  It is considerably thicker 
than the epidermis (1 to 10 mm) and mainly consists of intersecting collagen 
bundles. Besides hair follicles and glands, it also contains nerves, lymphatic 
conduits and blood vessels supplying nutrients and support (FitzGerald et al., 
2008; McQuestion, 2011). 
 
In literature, both acute and late radiation-induced skin reactions have been 
reported. The acute skin reactions generally originate from the naturally 
rapidly renewing epidermal layers. The late radiation-induced skin reactions, 
on the other hand, are mainly caused by damage to the supportive layers 
which have limited self-renewal potential (FitzGerald et al., 2008). 
Acute skin toxicity primarily originates from damage to the basal cell layer 
(Hopewell, 1990). As the stem cells in this layer are sterilized, they are 
prevented from proliferating and repopulating the epidermal layers. This 
process might result in dry or moist desquamation and has been reported for 
absorbed doses from 20-25 Gy (Archambeau et al., 1995). In response to the 
epidermal damage, erythema might develop as a secondary inflammatory 
response in the dermal structures (ICRP, 1992). At higher doses, more severe 
but rare stages include ulceration, haemorrhage and necrosis. As these early 
skin reactions are related to the natural renewal rate of the basal cell layer, 
they usually appear 2 to 3 weeks after the start of the radiotherapy course and 
mostly heal within one month after treatment completion (Wells, 2003). 
Late skin reactions, on the other hand, are defined as radiation-induced 
changes present beyond 90 days of treatment. They might include 
telangiectasia, atrophy, fibrosis, oedema, alopecia and ulceration 
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(Wong et al., 2013). In contrast to most acute skin radiation reactions, late 
skin toxicity usually prevails and persistently affects the patients' quality of 
life.  
Besides acute and late skin toxicity, exposure of the skin to ionising 
radiation has also been related to the induction of basal and squamous cell 
carcinoma. Conflicting evidence has been reported regarding the induction of 
melanoma (ICRP, 1992).  The contribution of skin exposure to the total 
effective dose and risk of stochastic effects is, however, considered relatively 
low. Therefore, in the context of radiotherapy with megavoltage photon 
beams, acute and late skin toxicity are usually considered the main dose-
limiting factor rather than the risk of skin cancer (ICRP, 1992). 
 
In skin dosimetry, the recommended depth for dose determination varies with 
the effect considered. The International Commission on Radiological 
Protection (ICRP) and the International Commission on Radiation Units and 
Measurements (ICRU) generally recommend skin dose assessments at 70 ?m 
and 1 mm depth for epidermal and dermal effects respectively (ICRP, 1992; 
ICRU, 1985). As previously mentioned however, skin layer thickness might 
vary considerably with the anatomical region, age and even between patients. 
In this respect, Devic et al. (2006) suggested to measure build-up doses at a 
wide range of depths and to extract the relevant skin dose at a case-specific 
depth defined by a radiation oncologist. 
 
1.2.2. Superficial target volumes 
In megavoltage photon radiotherapy, the build-up region also plays a major 
role in the treatment of superficial target volumes. Target volumes extending 
close to the skin mainly occur in the treatment of breast, chest wall and head-
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and-neck cancer. In these cases, adequate target coverage requires a boost of 
the inherently limited build-up doses. Such an increase in superficial doses is 
generally achieved through the application of bolus material (Hsu et al., 2008) 
or through tangentially incident photon beams (Tournel et al., 2007). 
 
1.3. The build-up region in megavoltage photon 
beams 
1.3.1. The physics of the build-up region 
The build-up region and its concomitant skin-sparing effect are one of the 
most distinct characteristics of megavoltage photon beams (figure 1.1). In all 
photon beams, the absorbed dose is not deposited by the photons itself, but 
by secondary charged particles generated during photon-tissue interactions. 
At therapeutic energies, these particles mainly include secondary electrons 
produced by Compton scatter. As these secondary electrons dominantly travel 
in the forward direction while depositing their energy, the absorbed dose rises 
steeply from the tissue-air interface towards the depth of the dose maximum 
(dmax). The region between the surface and the depth of dose maximum is 
generally referred to as the build-up region and exhibits, by nature, a lack of 
charged particle equilibrium (CPE). For a small irradiated volume, CPE exists 
if each charged particle of a given type and energy leaving the volume is 
replaced by a particle of the same type and energy entering the volume. Under 
this condition, the absorbed dose in the volume equals the collision kerma. A 
simplified illustration of the build-up to CPE in megavoltage photon beams 
is provided in figure 1.3.  
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Figure 1.3: Simplified diagram of the build-up to charged particle equilibrium, 
ignoring the beam attenuation and assuming one straight electron track generated in 
each depicted slab. Modified from: Johns H E and Cunningham J R, The Physics of 
Radiology, Thomas Publisher (1983). 
 
Assuming the generation of one secondary electron in each slab, CPE can 
obviously only be obtained at depths beyond the range of the secondary 
electrons (slab 4). As a consequence, the extent of the build-up region 
increases with the range of the secondary electrons and thus varies with the 
beam's energetic spectrum (Mayles, 2007).  
Additionally, due to the attenuation of the photon beam, the number of 
electrons generated in each slab will decrease with depth (neglected in figure 
1.3). Although charged particle equilibrium can be approximated under these 
circumstances, strict CPE generally does not exist. This condition, typically 
occurring at depths beyond the depth of the dose maximum in high-energy 
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photon beams, is referred to as transient CPE. Under transient CPE, the 
absorbed dose in the considered volume is proportional to the collision kerma.  
 
In practice, however, the skin-sparing effect of the build-up region is 
compromised by the presence of contaminant radiation and photons or 
electrons backscattered from the patient (Hounsell and Wilkinson, 1999). The 
contaminant radiation firstly consists of head scattered photons.  In standard 
linear accelerators, head scattered photons mainly originate from the 
flattening filter and, to a lesser extent, collimating devices and monitor 
chambers (Chaney et al., 1994). Besides head scatter photons, the 
contaminant radiation also contains electrons generated in the treatment head 
or in the traversed air volume. Both measurements and Monte Carlo (MC) 
simulations identified electrons produced in the treatment head as the 
dominant contamination source in modern linear accelerators (Medina et al., 
2005; Chibani and Ma, 2007). These electrons are mainly created within the 
flattening filter and monitor chamber (Petti et al., 1983; Sjogren and Karlsson, 
1996). The introduction of additional mass between the source and the patient, 
such as wedges, blocks, accessory trays or parts of couches and 
immobilization devices might further contribute to electron contamination 
(Kim et al., 1998). Air-generated electrons mostly have lower energies and 
become relatively more important for lower beam energies, smaller field sizes 
and larger source-to-surface distances (SSD) (Medina et al., 2005; Biggs and 
Russell, 1983).  
 
As the absorbed dose in the build-up region arises from a multitude of sources 
both within and outside the treatment head, its magnitude and nature depend 
on both the accelerator design and an array of clinical treatment parameters. 
Paelinck et al. (2005) reported considerable differences between the build-up 
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dose of both 6 and 18 MV beams produced by Varian versus Elekta 
accelerators. Besides treatment head design, multiple authors showed the 
build-up dose to depend on beam energy, field size, field shape, SSD, 
collimation and angle of incidence (Sjogren and Karlsson, 1996; Kim et al., 
1998; Klein et al., 2003; Dogan and Glasgow, 2003). Additionally, the 
presence of couch tops, support devices, bolus materials, or other objects in 
the vicinity of the patient might impact superficial doses (Hsu et al., 2008; 
Chiu-Tsao and Chan, 2010; Olch et al., 2014). 
 
1.3.2. Build-up dose measurements 
In build-up dosimetry, absorbed dose measurements are greatly complicated 
by the physical characteristics of the build-up region. The steep dose gradient, 
lack of CPE and the presence of contaminant radiation require the detector to 
have a high spatial resolution combined with a low energy dependence. 
Commonly used detectors include extrapolation chambers, fixed-separation 
plane parallel ionization chambers, thermoluminescent dosimeters, diamond 
detectors, diodes, MOSFETs and radiochromic film (O'Shea and McCavana, 
2003). 
 
Extrapolation chamber (EPC) dosimetry is generally considered the golden 
standard for build-up dosimetry in megavoltage photon beams (figure 1.4). 
Extrapolation chambers were initially developed to eliminate the effects of 
electron fluence perturbations arising from the presence of the air cavity in 
the medium (Nilsson and Montelius, 1986). The Böhm extrapolation chamber 
(type 23392, PTW Freiburg, Germany) has a collecting electrode with a 
diameter of 30 mm and a very thin entrance window (0.75 mg/cm²), limiting 
the effective point of measurement to at least 0.0075 mm (figure 1.4). By 
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adjusting the distance between the electrodes, the cavity ionization can be 
measured for multiple electrode separations and can be extrapolated to an 
infinitesimally small cavity volume. Multiple authors have described varying 
extrapolation methods, of which the most straightforward is the use of the 
relative cavity ionization extrapolated to zero electrode separation as an 
approximation of the relative absorbed dose (Nilsson and Montelius, 1986; 
Velkley et al., 1975; Tannous et al., 1981; Gerbi and Khan, 1990; Mellenberg, 
1990). As for all plane-parallel chambers, the cavity ionization should be 
determined under saturation conditions and should account for polarity 
effects (Gerbi and Khan, 1990). 
Although this method efficiently accounts for beam perturbations, 
conversion of the resulting depth-ionization curves to the depth-dose curves 
still requires accurate knowledge of the stopping-power-ratio (SPR). This 
ratio is known to be constant for depths beyond the depth of the dose 
maximum, but was shown to vary considerably with the contamination 
spectrum of the beam in the build-up region (Andreo and Brahme, 1986). 
Monte-Carlo simulations suggest that these SPR variations are most 
important in the first millimeter of the build-up region (up to 1.5% and 4% 
for 6 and 18MV beams respectively), but remain limited at greater depths 
(Abdel-Rahman et al., 2005). Modern techniques such as the use of flattening 
filter-free linear accelerators or the introduction of patient positioning devices 
in the beam might, however, impact the beam spectrum and therefore the 
variation of the SPR. For these techniques, accurate PDD determination in the 
first millimeter of the build-up region would require prior determination of 
the SPR variations. Additionally, extrapolation chambers are not widely 
available and very cumbersome and time-consuming to use. One 
measurement point requires at least 12 measurements: measurements need to 
be repeated at least twice at 2 voltage polarities for 3 electrode separations. 
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The acquisition of one PDD with 4 measurement points and one reference 
point requires, for example, approximately 3.5 hours. 
 
 
 
Figure 1.4: Cross section through the Böhm extrapolation chamber (type 23392, 
PTW Freiburg, Germany). The distance between the electrodes (6) and (7, entrance 
foil) can be adjusted using the micrometer screw (18). Modified from: Instruction 
manual Extrapolation chamber according to Böhm Type 23392, PTW Freiburg  
(2002). 
 
Fixed-separation plane parallel chambers are more practical to use but suffer 
considerably from perturbations of the electron fluence in the cavity volume. 
These perturbations mainly originate from electrons scattered from the cavity 
side and back walls and result in an overestimation of the ionization of up to 
15% (Gerbi and Khan, 1990; Nilsson and Montelius, 1986; 
Nilsson et al., 1996). In literature, perturbation correction factors are 
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available, but are specific to the considered chamber design, beam 
contamination spectrum and even the angle of incidence of the beam (Nilsson 
and Montelius, 1986; Velkley et al., 1975; Mellenberg, 1990; Gerbi and 
Khan, 1997). The polarity effect and directional dependence of plane-parallel 
chambers further complicate accurate dose determination (Gerbi and Khan, 
1990, 1997, 1987). 
 
Thermoluminescent dosimeters (TLDs) are mainly used for in vivo skin 
dosimetry or in combination with anthropomorphic phantoms (Quach et al., 
2000; Tung et al., 2004). They contain lithium fluoride or lithium borate and 
are available as powder, chips and rods. One of the main disadvantages of 
TLDs for build-up dosimetry, however, is their relatively large sensitive 
volume, resulting in a large effective depth of measurement and a 
considerable volume-averaging effect. 
 
Other commonly used point detectors include diamond detectors, silicon 
diodes, and MOSFETS. Compared to ionization chambers, diamond detectors 
are nearly tissue equivalent and do not require energy-dependent corrections 
(O'Shea and McCavana, 2003; Larraga-Gutierrez et al., 2015). The recently 
introduced synthetic microdiamond chamber (PTW-60019, PTW Freiburg, 
Germany) additionally offers a very small sensitive volume (0.004 mm³, 
thickness 1 ?m), rendering it an interesting detector for build-up dosimetry 
(Larraga-Gutierrez et al., 2015). Compared to the traditional natural diamond 
detectors, this synthetic detector also showed less variation of detector 
properties within the same detector type (De Angelis et al., 2002; Ralston et 
al., 2014). Silicon diodes and MOSFETs also have a small sensitive volume, 
but suffer from a low tissue equivalence, resulting in an energy-dependent 
response (O'Shea and McCavana, 2003; Cheung et al., 2009). 
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In contrast to all previously mentioned detectors, radiochromic film allows to 
measure two-dimensional dose distributions. Additionally, its excellent 
spatial resolution and low energy dependence (Sutherland and Rogers, 2010; 
Arjomandy et al., 2010) render it an excellent choice for build-up dosimetry. 
Modern EBT2 and EBT3 radiochromic films (Gafchromic, Ashland Specialty 
Ingredients, Wayne, NJ, USA) contain an active layer consisting of a 
diacetylene monomer (the lithium salt of pentacosa-10,12-diyonic acid 
(LiPCDA) 1 ). Following irradiation, the polymerisation of diacetylene 
monomers into acetylene polymers results in a dose-dependent film 
coloration.  
Film coloration is then analysed by film digitization and quantified by the 
optical density (OD), generally calculated as: 
?? ? ? ????
?
??
? 
with I0 and I representing the light intensity incident on and transmitted 
through the digitized film (figure 1.5(b)). The obtained OD depends on both 
the emission spectrum of the digitizer’s light source (E), the detection 
spectrum of the digitizer’s detector (S) and the film absorption spectrum (A). 
The corresponding absorption spectrum for the EBT2 radiochromic films is 
depicted in figure 1.5(a) and shows a major dose-dependent peak at 636 nm. 
Evidently, the conformity between the light source emission spectrum and 
the major peak in the film absorption spectrum will greatly impact the 
obtained sensitivity. For this reason, most dosimetric protocols use the optical 
density in the digitizer’s red color channel for film analysis and calibration. 
The use of the net optical density, obtained through digitization prior and after 
                                                     
1 Radiochromic Film, Presentation by Lewis D F, Ashland Specialty Ingredients, 20 
October 2010. 
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film irradiation, has also been shown to improve dosimetric accuracy 
(Paelinck et al., 2007). 
 
 
Figure 1.5: Absorption spectrum for the EBT2 radiochromic film (a) and 
determination of the radiochromic film optical density (b) through digitization. The 
obtained optical density depends on the emission spectrum of the light source (E) and 
the detection spectrum of the detector (S) in the densitometer, as well as on the film 
absorption spectrum (A). Modified from: Devic S 2011 Radiochromic film 
dosimetry: Past, present, and future Phys Medica 27 122-34 
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Currently, two types of radiochromic film, EBT2 and EBT3, are 
commercially available. An extensive overview of the properties of EBT2- 
and EBT3- type films is available in Andres et al. (2010) and in Reinhardt et 
al. (2012) respectively. The accuracy of radiochromic film dosimetry, 
however, does not only depend on the properties of the film, but on the 
complete-film digitizer system. Flatbed transmission scanners are the most 
commonly used digitizers and are extensively discussed in literature 
(Gluckman and Reinstein, 2002; Paelinck et al., 2007; Ferreira et al., 2009). 
 
1.3.3. Build-up dose calculations 
Similar to build-up dose measurements, build-up dose calculations comprise 
a complicated challenge. Calculation algorithms need to account for all focal 
and extrafocal sources and effectively model their variation with machine 
design and treatment plan parameters. 
In this respect, the most accurate approach is to perform a full Monte Carlo 
(MC) simulation of the complete beam delivery system. This technique 
simulates the electrons exiting the accelerator flight tube and, using random 
number generation and cross section data, tracks their paths and interactions 
through the accelerator head (Verhaegen and Seuntjens, 2003). In the build-
up region of 6MV beams, MC calculations have been reported to agree within 
1% at 50 ?m depth (depth-ionization) and within 3.6% at 0.5 mm depth 
(depth-dose) to extrapolation chamber measurements (Abdel-Rahman et al., 
2005; Parsai et al., 2008). For higher beam energies, considerably higher 
discrepancies have been reported for multiple MC codes (Ding, 2002; Abdel-
Rahman et al., 2005; Chibani and Ma, 2007). In literature, these inaccuracies 
have been attributed to the presence of the ionization chamber (Abdel-
Rahman et al., 2005) or inaccuracies in the treatment head model (Chibani 
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and Ma, 2007), but have more recently been discussed to originate from a bug 
in the respective Monte Carlo codes 2. 
Most commercially available treatment planning systems (TPS), however, 
do not use full MC calculations but rely on virtual source models (VSM) to 
characterize the beam delivery system. These models use analytical 
representations of virtual particle sources to calculate the particle fluence at 
the patient surface. They generally include spatial distribution functions for a 
primary photon source, a head-scattered photon source and an electron 
contamination source (Fippel et al., 2003; Sikora et al., 2007). Each 
distribution function is characterized by both geometrical and spectral 
parameters that are tuned to the beam's specific characteristics. The required 
input data are usually derived from beam data measurements, but can also be 
extracted from full Monte Carlo simulations of the treatment head (Fix et al., 
2001; Sikora and Alber, 2009). Virtual source models have been designed for 
a wide range of analytical dose calculation algorithms, including pencil beam 
and collapsed-cone convolution/superposition algorithms (Ahnesjo et al., 
1992; Ahnesjo, 1994; Liu et al., 1997). More recently, VSM have also been 
implemented in Monte Carlo- based TPS to provide the particle fluence input 
for the MC calculations within the patient volume (Fippel et al., 2003; Sikora 
and Alber, 2009).  
Evidently, the accuracy of VSM-based TPS in the build-up region does 
not only depend on the virtual source model itself, but also on the 
characteristics of the complete calculation engine, the accuracy of measured 
input data and the planning parameters (Hsu et al., 2010). In literature, 
discrepancies of up to 25% between build-up measurements and VSM-based 
calculations were found, with large variations depending on the treatment 
                                                     
2 Personal communication with Dr. Nick Reynaert. 
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technique, the dosimetry method, the considered depth and calculation 
parameters such as calculation grid size (Hsu et al., 2010; Court et al., 2008; 
Panettieri et al., 2009; Chung et al., 2005). 
 
1.4. The evolution of build-up dose with treatment 
technology 
In the early days of radiotherapy, beam delivery technology limited 
therapeutic x-ray energies to the kilovoltage range. In these beams, a 
relatively high proportion of the dose was absorbed in the skin, resulting in 
severe acute skin reactions that compromised the dose to deep-seated tumours 
(Bernier et al., 2004; FitzGerald et al., 2008). Since the introduction of 
megavoltage photon beams through Cobalt-60 units and linear accelerators 
however, the presence of the build-up region allowed to limit superficial 
doses while boosting the tumour doses at depth (FitzGerald et al., 2008). 
 
1.4.1. Intensity modulated radiotherapy 
The development of intensity modulated radiation techniques during the 
1980s and 1990s further allowed to reduce radiotherapy side effects 
(Veldeman et al., 2008). Through beam modulation and segmentation, this 
technique allows to create more conformal dose distributions, thus shaping 
the prescribed dose to the target volume and reducing the dose to the 
surrounding healthy tissues (Brahme et al., 1982). In the build-up region, the 
impact of IMRT depends on the treatment modality used.  
For IMRT implemented through standard linear accelerators equipped 
with multi-leaf collimators (MLC), most authors agree that the MLC-based 
beam modulation does not increase superficial doses itself. Dogan and 
40 INTRODUCTION,  OBJECTIVES  AND  OUTLINE 
 
Glasgow (2003) for example, demonstrated that superficial doses in both 
segmented and dynamic IMRT fields do not exceed the values of the 
corresponding static fields. Yokoyama et al. (2004) equally studied build-up 
doses as a function of field segmentation and reported slightly lower build-up 
doses for multi-segment compared to static fields. IMRT plans, however, 
differ considerably from conventional treatment configurations with respect 
to the used field sizes, angles of incidence and SSDs. The impact of these 
variations was found to depend on both tumour site and treatment technique. 
For breast cancer for example, Almberg et al. (2011) found similar superficial 
doses for conventional and tangential IMRT treatments, but detected much 
lower skin doses for a 7-field IMRT technique including non-tangential 
fields. Clinically, multiple studies documented parallel improvements in 
breast cosmesis and skin toxicity for breast-IMRT compared to the 
conventional wedged tangential fields (Freedman et al., 2004; Harsolia et al., 
2006). For IMRT-treated head-and-neck cancer patients in contrast, increased 
skin reactions were reported and attributed to the increased use of tangential 
beams, the bolus effect of thermoplastic masks or the inclusion of the skin in 
the target volume (Lee et al., 2002; Higgins et al., 2007). 
For IMRT-plans implemented through tomotherapy, considerably 
different build-up doses were reported. In tomotherapy, fan beams are 
delivered through a fan beam collimator on a standard linear accelerator 
(serial tomotherapy) or through a binary collimator on a tomotherapy machine 
(helical tomotherapy). Depending on the beam delivery system, these build-
up dose differences were related to the fan beam collimator design in serial 
tomotherapy or the absence of a flattening filter in helical tomotherapy. 
Roland et al. (2008) compared skin doses for equivalent serial and helical 
tomotherapy and step-and-shoot IMRT plans for head-and-neck and prostate 
cancer treatments and detected the highest superficial doses for helical 
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tomotherapy executed on a Hi-Art II-Tomotherapy system (Tomotherapy 
Inc., Madison, WI). Serial tomotherapy resulted in considerably smaller skin 
doses, followed by step-and-shoot IMRT on a conventional linear accelerator. 
Smith et al. (2008), on the other hand, reported the build-up doses of the 6MV 
static tomotherapy beam of the Hi-Art Tomotherapy system to be 31% 
smaller compared to a standard linear accelerator. Capelle et al. (2012) 
compared in vivo measurements of skin dose in adjuvant breast radiotherapy 
by skin-sparing helical tomotherapy versus 3D-conformal radiotherapy and 
found that the skin-sparing helical tomotherapy plans resulted in improved 
skin dose homogeneity. 
 
1.4.2. Volumetric arc therapy 
More recently, volumetric arc therapy offers the potential to perform intensity 
modulation by a continuously moving MLC during gantry rotation, rather 
than by MLC-modulation from a series of static gantry angles in classic IMRT 
(Teoh et al., 2011). A comparison of VMAT versus step-and-shoot IMRT 
treatments for brain, head-and-neck and prostate patients demonstrated skin 
dose differences of up to 38% (Defoor et al., 2013).  The direction of these 
differences depended upon the tumour site, whereas their magnitude equally 
varied between patients. 
 
1.4.3. Patient positioning and immobilization devices 
While the introduction of IMRT and VMAT allows to create highly 
conformal dose distributions, it evenly increases the importance of accurate 
patient positioning and immobilization. In clinical practice, set-up accuracy 
is generally achieved by using both image-guided radiation techniques 
(IGRT) and a wide range of patient positioning devices, such as body 
42 INTRODUCTION,  OBJECTIVES  AND  OUTLINE 
 
immobilization bags, head holders and thermoplastic shells.  In a recent 
AAPM-Task group report, Olch et al. (2014) emphasized that the dosimetric 
effects of these devices, including build-up dose perturbations, can be 
clinically relevant, but are often overlooked. For 6MV beams traversing 
vacuum immobilization bags or thermoplastic immobilization masks, for 
example, superficial doses were found to increase by approximately 50% 
(Hadley et al., 2005; Johnson et al., 1995; Cheung et al., 2002). Intentional 
stretching of these thermoplastic masks results in a smaller mask density and 
thickness and limits the surface dose increase, but equally affects set-up 
reproducibility (Hadley et al., 2005; Olch et al., 2014). 
 
1.4.4. Dose calculation accuracy 
For these increasingly complex treatment techniques, multiple authors have 
reported considerable discrepancies between build-up dose measurements 
and calculations for a variety of treatment planning systems. For head-and-
neck IMRT, Chung et al. (2005) found two commercially available TPS to 
overestimate the absorbed dose from the surface to 2 mm depth with 7.4% to 
18.5% of the prescribed dose. Similarly, Higgins et al. (2007) reported 
discrepancies between measurements and calculations of approximately 10% 
for both an IMRT and tomotherapy head-and-neck case. For 6MV tangential 
beams applied in breast cancer IMRT, Panettieri et al. (2009) found small 
differences between MC simulations and calculations by the analytical 
anisotropic algorithm (AAA) and pencil beam (PB) implemented in the 
Eclipse TPS (Varian Medical Systems). While these discrepancies in 6MV 
beams were considered clinically irrelevant, larger discrepancies between 
MC simulations and TPS calculations were documented for the 18MV 
tangential beams. For the Hi-Art tomotherapy system, multiple authors have 
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demonstrated the Hi-Art TPS to overestimate superficial doses by 
approximately 3% to 15% for various treatment sites (Ramsey et al., 2007; 
Tournel et al., 2007; Ito et al., 2011; Capelle et al., 2012; Avanzo et al., 2013). 
One specific feature of this TPS is the use of skin flashes for treatment of 
superficial targets, creating local dose gradients to compensate for the build-
up effect. The accuracy of this technique was shown to strongly depend on 
the patient set-up accuracy. For head-and-neck treatments, small changes in 
patient volume or position were shown to lead to underdosages between 1% 
and 25% or overdosages of up to 10% (Tournel et al., 2007). 
 
 1.5. Objectives and outline 
Considering the evolution of build-up doses with treatment technology and 
the reported inaccuracies in build-up dose calculations, the general objective 
of this dissertation was to evaluate the impact of recent evolutions in 
treatment technology on build-up dose and build-up dose calculation 
accuracy in megavoltage photon radiotherapy.  
 
As radiochromic film was selected as the main build-up dosimeter, our first 
objective was to optimize radiochromic film dosimetry for high-gradient 
dosimetry in the build-up region. To that purpose, we compared and 
optimized the performance of two transmission scanners for EBT2 dosimetry 
(Gafchromic, Ashland Specialty Ingredients, USA) (Chapter 2). 
 
The following recent evolutions were expected to have the greatest impact 
with regard to the build-up region: the removal of the flattening filter in 
standard linear accelerators and the increasing use of patient positioning 
devices (Olch et al., 2014).  
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Flattening filter-free linear accelerators have recently become commercially 
available, as they offer reduced out-of-field doses and faster delivery times 
compared to conventional accelerators. However, as the flattening filter is the 
main source of electron contamination in megavoltage photon beams, its 
presence also impacts build-up doses and build-up dose calculations. In this 
respect, the second objective of this dissertation was to compare the absorbed 
dose and calculation accuracy in the build-up region of flattened versus 
unflattened megavoltage photon beams (Chapter 3). 
 
Patient positioning devices, on the other hand, have become increasingly 
important to guarantee accurate patient set-up in the delivery of highly 
conformal dose distributions (Olch et al., 2014). However, the presence of 
external materials in the vicinity of the patient might cause build-up dose 
perturbations in beams traversing these devices. Therefore, our third objective 
was to quantify the dosimetric effects of the AIO patient positioning device 
and to assess the feasibility to include these effects during treatment planning 
calculations (Chapter 4). Even though this investigation was initiated for the 
prone breast set-up of the patient positioning device, the general conclusions 
remain valid for all set-ups that use the same base-plate and cushion material. 
 
While the evolutions addressed in Chapter 3 and 4 unintentionally impact the 
dose build-up, modern treatment techniques can also be used to intentionally 
control superficial doses. In this respect, the last objective of this dissertation 
was to investigate the potential of volumetric arc techniques to reduce the 
dose to the hair follicles and prevent temporary alopecia in whole brain 
radiotherapy (Chapter 5). 
 
Chapter 6 finally contains a general discussion and conclusion. 
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Abstract 
This study evaluates the performance of the Nikon Coolscan 9000ED film 
scanner for high-gradient radiochromic film dosimetry. As a reference for 
comparison, analogue experiments were performed on the Epson Expression 
10000XL flatbed scanner. Based on these results, a dosimetric protocol was 
established for the Nikon scanner and its overall performance for high-
gradient dosimetry was evaluated. The Nikon scanner demonstrated a high 
sensitivity for radiochromic film dosimetry, resulting in more contrast in the 
digitized image. The scanner's optics also demonstrated an excellent stability 
and did not necessitate warm-up scans prior to data-acquisition. Moreover, 
negative effects of temperature changes of the film inside the scanner were 
shown to be limited. None of the digitized images showed significant 
disturbances by moiré-patterns, by virtue of the absence of a glass plate for 
film positioning. However, scanner response was found to vary considerably 
across the reading area, requiring an optical density-dependent correction 
procedure to be incorporated into the scanning protocol. The main limitation 
of the Nikon Coolscan 9000ED transmission scanner remains its film size 
restriction to 6.2 x 20 cm². Nevertheless, its excellent characteristics render it 
the preferential tool for high-gradient radiochromic film dosimetry in 
applications limited to small film sizes, such as dosimetry in the build-up 
region. 
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2.1. Introduction 
While radiochromic film dosimetry was originally developed for quality 
assurance of advanced irradiation techniques, it has proven to be a valuable 
tool for various dosimetric purposes. Due to its high spatial resolution and 
low energy dependence (Sutherland and Rogers, 2010; Arjomandy et al., 
2010), it has been extensively used in clinical dosimetry, including dosimetry 
in the build-up region of megavoltage photon beams (Bilge et al., 2009; 
Cheung et al., 2002; Devic et al., 2006a; Qi et al., 2009; Kelly et al., 2011; 
Chiu-Tsao and Chan, 2010; Quach et al., 2000). 
However, the obtained accuracy in radiochromic film dosimetry does not 
uniquely depend on the qualities of the film, but on the complete film-digitizer 
system. Charge-coupled device (CCD)-based flatbed scanners, that are 
commercially available and widely used for radiochromic film digitization, 
suffer from several artefacts when scanning radiochromic films. Commonly 
observed artefacts comprise moiré-patterns, arising from partial reflections at 
the film-glass bed interface (Gluckman and Reinstein, 2002). Moreover, these 
scanners generally employ fluorescent lamps as a light source. These lamps 
suffer from warm-up effects (Ferreira et al., 2009; Paelinck et al., 2007) and 
generate heat affecting the film optical density (OD) (Lynch et al., 2006; 
Buchauer et al., 2009). Polarization of light transmitted through the EBT and 
EBT2 film type also results in an orientation dependent and laterally non-
uniform scanner read-out (Richley et al., 2010; Ferreira et al., 2009). These 
artefacts all originate in the specific properties of the film-flatbed scanner 
combination, complicating dosimetric procedures and inducing measurement 
uncertainties. 
The Nikon Coolscan 9000 ED scanner (Nikon Co., Tokyo, Japan), 
however, is specifically designed as a high-quality film transmission scanner. 
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This scanner does not employ a glass bed for film positioning, thus limiting 
optical density disturbances by moiré-patterns.  Moreover, its LED light 
source is designed not to require any warm-up scans and not to generate heat 
affecting the film optical density. Its high maximum optical resolution (4000 
dpi) and broad dynamic range are major advantages for optical density 
measurements in steep spatial gradient regions such as the build-up region. 
The primary objective of this study is an assessment of the Nikon Coolscan 
9000 ED transmission scanner’s performance for radiochromic film 
dosimetry, with specific interest in high-gradient dosimetry. To that purpose, 
we investigated its sensitometric curve for different film orientations and 
uncertainties associated with local OD variations, arising from, for instance, 
electronic noise. Furthermore, scanner response uniformity and potential drift 
and warm-up effects were evaluated. Based on these results, a dosimetric 
protocol was established and its overall performance in high-gradient 
dosimetry was evaluated. When relevant, similar experiments were 
performed with the Epson Expression 10000XL flatbed scanner as a reference 
for comparison. This scanner is recommended by the radiochromic film 
manufacturer (International Specialty Products, Wayne, NJ, USA) and widely 
used for radiochromic film dosimetry. 
2.2. Materials and Methods 
2.2.1. Digitizers 
The Nikon Coolscan 9000 ED transmission scanner 3 (Nikon Co., Tokyo, 
Japan) is specifically designed as a high-quality multi-format film scanner. It 
3 Nikon Film Scanner Super Coolscan 9000ED Manual, Nikon Co., Tokyo, 2003, 
http://www.nikon.com 
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employs fixed optics, whereas the film media are moved in film holders by a 
parallel single-pass scanning system. As a consequence, film size is limited 
by the film holder's size: the largest film holder accommodates films up to 6.2 
cm wide and 20 cm long. Additionally, the scanner's reading area is limited 
to 5.9 x 8.3 cm². Larger films need digitization in multiple sessions and 
registration of the resulting images. The film holders do not employ a glass 
bed for film positioning. The optical system consists of red, green and blue 
(RGB) and infrared LEDs with a rod disperser and a light output slot, coupled 
to a three-line monochrome linear CCD. Colour separation is provided by 
alternatively activating the RGB LEDs. The Nikon Coolscan 9000 ED has a 
maximum optical resolution of 4000 dpi and a maximum pixel depth of 16 
bits per colour channel. The scanner is not automatically calibrated between 
successive scans. If required, however, scanner calibration can be performed 
on demand.  
The use of the Epson Expression 10000 XL flatbed scanner is 
recommended by the film manufacturer and extensively documented in 
literature (Ferreira et al., 2009; Richley et al., 2010; Andres et al., 2010; 
Martisikova et al., 2008; Desroches et al., 2010). Films are positioned on a 
glass scan bed and illuminated by a translating xenon gas cold cathode 
fluorescence lamp, coupled to a CCD sensor. It has a maximum optical 
resolution of 2400 dpi and a reading area of 31.0 x 43.7 cm².  
 
2.2.2. Film irradiation and digitization 
As a default, film irradiation and analysis was performed using the following 
parameters and methods. Relevant deviations from these standards are 
described in the respective methods sections. 
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Gafchromic EBT2 film pieces (lot no A11011003, International Specialty 
Products, Wayne, NJ, USA) were irradiated at an Elekta Synergy linear 
accelerator (Elekta, Crawley, West-Sussex, UK) equipped with the Beam 
Modulator multileaf collimator (MLC). The films were positioned centrally 
in a polystyrene slab phantom (Polystyrol 495F, BASF, Germany, ρ = 1.02 
g/cm³) at 10 cm depth in a 6 MV photon beam. The source-to-surface distance 
(SSD) and field size were 90 cm and 9.6 x 10.4 cm² respectively. In order to 
obtain the highest possible accuracy, all film pieces were stored in light-tight 
envelopes 4 and handled carefully with gloves. Absolute dose measurements 
were performed concurrently with a Farmer ionization chamber type 
TM30010-1 in combination with a Unidos electrometer (PTW Freiburg, 
Freiburg, Germany). 
On both digitizers, EBT2 films were scanned in the central scanner region 
in transmission mode. Scanning resolution was always 100 dpi. Except for 
the first experiments examining the orientation dependence of the optical 
density read-out, films were positioned in portrait orientation (coating 
direction, paralleling the short dimension of the original film sheet, 
perpendicular to the scanning direction) in all following experiments. All 
image enhancement features were turned off. In order to minimize the effect 
of post-exposure density variations of the EBT2 film (Devic et al., 2010), 
EBT2 film pieces were scanned at least 36 hours after irradiation. As a 
default, images were not corrected for non-uniformity of the scanner 
response. Image data were stored in 48-bit RGB uncompressed TIFF-format 
and analyzed in Matlab version 7.10 (The Math Works, Inc., Natwick, MA, 
USA). Film analysis was uniquely performed on the red colour channel data. 
On the Nikon scanner, the dedicated driver software package Nikon Scan 
4 The film pieces were intermittently stored in light-tight envelopes, but were taken 
out from the envelopes during irradiation. 
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Version 4.0.2. was used with the value of "Gamma" set to 1.0 to have the 
scanner output linear in the transmittance T of the film. The Epson scanner 
was used with the software package "EPSON scan" in professional mode.  
The conversion into OD was carried out externally to the acquisition software 
of both scanners, according to (1): 
??? ? ?? ????? ?
?
??
? ? ? ????? ?
??
???
?   (1) 
with I0, I and PV representing the light intensity incident on and transmitted 
through the digitized film and the corresponding pixel value respectively. 
For the Epson Expression scanner, additional precautions were taken to 
obtain the highest possible accuracy and ensure a fair comparison to the 
Nikon Coolscan 9000 ED scanner. Six warm-up scans were performed prior 
to data acquisition, in order to minimize the influence of its well-known light 
source warm-up effect (Ferreira et al., 2009). Furthermore, the Epson scan 
bed temperature was continuously monitored with an infrared thermometer 
(Thermophil T 203, Ultrakust Gerätebau GmbH, Ruhmannsfelden, Germany) 
and kept constant within ±1°C.  
 
2.2.3. Experiments 
2.2.3.1. Sensitometric curves and orientation dependence.   
For a given type of radiochromic film and post-irradiation time, the 
sensitometric curve depends on both the densitometer used and the film 
orientation. The former dependence is related to the degree of matching 
between the film absorption spectrum and both the light source emission 
spectrum and the detector's sensitivity spectrum. The latter dependence is 
associated with the general structure of the radiochromic film and the 
structure of its active layer. The anisotropic orientation of the diacetylene 
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polymers in the EBT2 sensitive layer polarizes incident light, thereby causing 
an orientation dependent optical density response in most scanners (Lewis, 
2010). 
Accordingly, sensitometric curves were determined for both scanners and 
for all 8 possible film orientations. To that purpose, 7  EBT2 film pieces 
(3.5 x 3.5 cm²), irradiated to 0, 29, 71, 130, 204, 295 and 403 cGy, were 
digitized in the scanners' central region 5. Mean OD values were computed in 
a central, clearly delineated region of interest (ROI, 1.14 x1.14 cm², 2025 
pixels). The same ROI was used for all film orientations. Net OD values were 
obtained by pixel wise subtraction of the blank film OD (2): 
???? ? ? ??????? ? ???????   (2) 
with ODpost and ODprior representing the OD read-out after and prior to 
irradiation respectively. To that purpose, film markings were used for 
registration of the images digitized after and prior to irradiation. Film pieces 
positioned with their coating direction perpendicular to the scanning direction 
are further referred to as "portrait" oriented. This orientation corresponds to 
the long dimension of the original EBT2 film sheet paralleling the scanning 
direction. A 90° rotation of the film in the scan bed plane results in a 
"landscape" orientation. In the portrait and landscape orientations, the film's 
thick polyester base layer faces the glass bed and film holder in the Epson and 
Nikon scanner respectively. On the contrary, films in the "flipped" orientation 
have their thin coating layer facing the glass bed or film holder. 
Subsequently, the statistical significance of the orientation dependent OD 
alterations was investigated. Three film pieces (0, 130 and 295 cGy) were 
scanned 10 consecutive times in all 8 orientations. Two-tailed t-tests 
                                                     
5 The sensitometric curves were determined using a Farmer ionization chamber (type 
30010, PTW Freiburg, Germany). The traceability to a primary standard was ensured 
by calibration of this chamber in a standard laboratory. 
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(significance level 0.05) were performed on the datasets containing the mean 
OD values in the central ROI for all 8 orientations. 
 
2.2.3.2. Local response fluctuations.  
Even in small ROIs in uniformly irradiated films, optical densities fluctuate 
on a  pixel-to-pixel basis with respect to their mean value. Apart from the 
random nature of the dose absorption process, these fluctuations are 
associated with both film and scanner dependent factors (Niroomand-Rad et 
al., 1998; Bouchard et al., 2009). Firstly, they are closely related to the 
structure of the film sensitive layer, structural artefacts or even scratches or 
dust particles on the film (Butson et al., 2003; Bouchard et al., 2009). 
Secondly, they arise from digitizing artefacts such as moiré-patterns or 
electronic noise. Next to the inevitable shot noise, electronic scanner noise is 
associated with scanner-specific characteristics, for instance the dark current 
in the CCD. Moreover, for each scanner, the magnitude of the local 
fluctuations depends on the spatial resolution used (Butson et al., 2003). OD 
uncertainties associated with these local fluctuations are generally quantified 
by the relative standard deviation of the OD with respect to their mean value 
in the considered ROI (Niroomand-Rad et al., 1998). Moreover, it must be 
noted that these OD uncertainties are not equal to uncertainties in terms of 
absorbed dose: the conversion of OD uncertainty into dose uncertainty 
depends on the slope of the sensitometric curve.  
In this study, both OD and dose uncertainties were computed for both 
scanners as a function of absorbed dose and scanning resolution.  Therefore, 
the seven EBT2 films were scanned in the central scanner region at a 
resolution of 100, 800 and 2400 dpi. The OD standard deviation was 
computed in a rectangular ROI of 20.32 x 2.54 mm². The small size of the 
ROI in the CCD-direction was intended to minimize the influence of lateral 
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non-uniformities in scanner response on the standard deviation computation. 
As we did not expect such non-uniformities in the scan direction, the size of 
the ROI in this direction was significantly larger. The geometric size and 
location of the ROI was kept constant for the different resolutions in order to 
avoid film inhomogeneities or scanner response non-uniformities to influence 
the results. Consequently, the considered ROI contains 800, 51 200 and 460 
800 pixels for a resolution of 100, 800 and 2400 dpi respectively. The 
contribution of the local OD variations to dose uncertainty was estimated by 
multiplying the OD uncertainty with the first derivative of the OD-to-dose 
calibration curve at the considered dose level, a method adopted from 
(Baldock et al., 2001) and (Fuss et al., 2007). To this purpose, a third order 
polynomial fit to the experimental data was used.    
2.2.3.3. Scanner response uniformity.  
When scanning uniformly irradiated film pieces on commercially available 
CCD-based scanners, numerous studies have reported larger scale non-
uniformities in OD response across the scanner's reading area. This effect is 
extensively documented for EBT type radiochromic film (Paelinck et al., 
2007; Lynch et al., 2006; Ferreira et al., 2009; Saur and Frengen, 2008; 
Martisikova et al., 2008) and has equally been observed for the EBT2 type 
radiochromic film (Richley et al., 2010). Response variations are generally 
larger in the CCD-direction than in the scan direction. Moreover, the response 
non-uniformity depends on the OD, with larger variations being found for 
lower optical densities. According to the manufacturer, this effect can be 
ascribed to polarization of the light transmitted through the film (Lewis, 
2010). 
In order to investigate these effects on the Nikon Coolscan 9000ED 
scanner, EBT2 film pieces (6.2 x 10 cm²) were uniformly irradiated to an 
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absorbed dose of 0, 29, 128 and 397 cGy.  This was achieved by irradiating 
them in a polystyrene slab phantom (30 x 30 x 40 cm³) at 20 cm depth at the 
Elekta SLiplus (Elekta, Crawley, UK) linear accelerator equipped with the 
Elekta standard MLCi multileaf collimator in a 6MV photon beam. Field size 
at isocenter and SSD were 25 x 25 cm² and approximately 200 cm 
respectively. Irradiation field uniformity was checked along the two principal 
axes using a water tank and found to be constant within 1.1%. For each dose 
level, 4 film pieces were irradiated in different orientations with respect to the 
irradiation field. All pieces were positioned with their thin polyester layer 
facing the radiation source, but rotated 90° with respect to each other. 
Averaging the optical densities over these 4 films reduces the impact of 
residual field and film inhomogeneities. As for local response fluctuations, 
scanner response uniformity was evaluated in terms of both OD and dose. 
 
2.2.3.4. Drift and warm-up effects.  
Various causes of OD measurement drift have been described for 
commercially available flatbed scanners. Firstly, instabilities in scanner 
properties, such as the light output or the detector's sensitivity, may cause 
read-out variations.  Secondly, fluorescent lamps need warm-up scans in 
order to stabilize the light output and thus the optical density read-out 
(Paelinck et al., 2007; Ferreira et al., 2009). The Epson Expression 10000XL, 
for example, requires at least 7 warm-up scans prior to data-acquisition 
(Ferreira et al., 2009). Finally, radiochromic film transmission spectra have 
been shown to depend on film temperature. Spectroscopic studies of the 
Gafchromic EBT film type demonstrated a shift to lower wavelengths of the 
main absorption peaks and a decrease of the  peak maxima absorption 
(Buchauer et al., 2009). Both effects were found to be reversible with 
temperature. These findings have important consequences for dosimetry 
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protocols using commercially available flatbed scanners, as their fluorescent 
scanner lamps generate heat and warm the film on the scanner bed. Lynch et 
al. reported OD changes of approximately 7% for film temperatures between 
18 and 33°C on an Epson flatbed scanner (Lynch et al., 2006).  
For the Nikon scanner, these various types of scanner drift were 
investigated by scanning 4 EBT2 film pieces (2.2 x 2.2 cm², irradiated to 0, 
71, 204 and 403 cGy respectively) together with an OD step wedge in three 
subsequent scan series. A first scan series (series 1) consisted of 100 
consecutive scans, between which no inter-scan calibration was performed. 
This series was followed by a scanner calibration and 40 consecutive scans 
separated by 2-minute scanner calibration intervals (series 2). Both the films 
and the step wedge were then removed from the scanner and allowed to cool 
down for one hour, during which the Nikon scanner remained turned on. A 
final scan series (series 3) of 40 scans was subsequently completed. In this 
series, inter-scan calibration was equally performed between successive 
scans. Each of these scan series took approximately 1.5 hours.  
As a reference for comparison, we also scanned the OD step wedge and 4 
EBT2 film pieces (2.2 x 2.2 cm², lot no F03181002, irradiated to 0, 71, 201 
and 396 cGy) one hundred consecutive times on the Epson scanner. Scan bed 
temperature was monitored at the start and the end of the scan session. Each 
scan, including the automatic scanner calibration, took approximately 30 
seconds.  
 
2.2.3.5. Overall performance.  
Finally, we evaluated the overall performance of the Nikon scanner-EBT2 
combination for high-gradient dosimetry by comparing the measured dose 
build-up in a 6 MV photon beam to ionization chamber data. Additionally, 
the measured dose distribution in an IMRT-beam containing steep dose 
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gradients was compared to treatment planning data, thus illustrating the 
application of the film-scanner combination for two-dimensional dose 
verification in high gradient dosimetry 6. 
The absolute dose build-up was measured in a 6 MV photon beam, with 
field size at isocenter and SSD being 9.6 x 9.6 cm² and 90 cm respectively. 
The films (6.2 x 10 cm²) were consecutively irradiated in the polystyrene slab 
phantom at the Elekta Synergy linear accelerator in a parallel orientation 
containing the beam axis. The maximum absorbed dose amounted to 250 cGy. 
Consecutive measurements with a Markus plane-parallel chamber 7  (type 
23343, PTW Freiburg, Freiburg, Germany) were performed as a reference for 
comparison. As the Markus chamber is known to overestimate absorbed dose 
at shallow measurement depths (Gerbi and Khan, 1990), measurements were 
confined to depths greater than 2 mm: 2.03, 3.03, 4.03, 5.03, 6.03, 8.03, 10.03, 
12.03, 13.03, 14.03, 15.03 and 20.03 mm. This was achieved by successively 
adding polystyrene slabs (1 or 2 mm thickness) on top of the slab stack. In 
this depth range, preliminary research confirmed the overestimation of the 
Markus chamber with respect to extrapolation chamber measurements to be 
within 1.59%. Both film and chamber measurements were repeated three 
times.  
The two-dimensional dose verification was performed in the polystyrene 
slab phantom for a 6 MV IMRT-beam containing multiple steep dose 
gradients up to 58.55 cGy/cm. The maximum absorbed dose amounted to 
                                                     
6 The two-dimensional dose verification cannot be considered as an evaluation of the 
film performance, as the dose calculations cannot be considered a reliable reference 
for comparison. The dose calculation accuracy will strongly depend on the beam 
model and calculation algorithm. Therefore, the IMRT dose verification should rather 
be considered as an illustration of a two-dimensional application of the film-digitizer 
combination.  
7 The traceability to a primary standard was ensured by calibration of this chamber in 
a standard laboratory. 
68 HIGH-GRADIENT  RADIOCHROMIC  FILM  DOSIMETRY 
177.27 cGy. A cutout of the absorbed dose distribution was measured using 
three radiochromic films (6.2 x 10 cm²) at a Clinac iX linear accelerator 
(Varian Medical Systems, Palo Alto, CA). Absorbed dose computations were 
performed using the analytical anisotropic algorithm (AAA) implemented in 
the Eclipse treatment planning system (version 8.9.08, Varian Medical 
Systems, Palo Alto, CA). These measured and calculated dose distributions 
were compared using a two-dimensional gamma evaluation with tolerance 
levels 3% - 3mm 8. 
In these experiments, the overall performance of the Nikon scanner-EBT2 
combination was optimized by converting the results of the preceding 
experiments into the following dosimetric protocol. As a default, the general 
scanner settings described in Section 2.2.2 were used: radiochromic films 
were scanned in the 48-bit RGB transmission mode with a resolution of 100 
dpi. Films were positioned in portrait orientation and all image enhancement 
scanning features were turned off. Furthermore, all images were corrected for 
scanner response non-uniformities using OD-dependent correction matrices. 
Each film was scanned only once, with scanner calibration being performed 
between all scans. Absorbed dose profiles were computed by column wise 
averaging the 10 central profiles for each of the films. 
In this respect, repeatedly reported film inhomogeneities in early EBT2 
film lots are especially noteworthy (Hartmann et al., 2010; Kairn et al., 2010). 
Hartmann et al. (2010) reported such inhomogeneities in Gafchromic EBT2 
film leading to differences in absorbed dose computation of more than 6% at 
1 Gy, even when using net OD for calibration. Our previous research on early 
radiochromic film lots equally demonstrated these artefacts, generally 
8 The gamma-evaluation was performed with tolerance levels equalling 3mm – 3% 
of the local dose. Film measurements were used as the reference dose distribution. A 
cutout of the dose distribution (5x6 cm²) in the vicinity of the isocenter was used as 
the region of interest. No cut-off values were used. 
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appearing as a band-like pattern disturbing the measured dose distribution. In 
this experiment, these film response inhomogeneities are corrected for by 
using net optical densities, generated by pixel wise subtraction of images 
obtained prior to irradiation from images obtained 36 hours after irradiation. 
 
2.3. Results 
2.3.1. Sensitometric curves and orientation dependence 
Figure 2.1 compares the sensitometric curves for EBT2 film pieces digitized 
in different orientations on the Nikon and the Epson scanner. A third order 
polynomial fit to the calibration data is displayed.   
For both scanners, optical densities do not differ significantly when 
rotating the film 180° in the scan bed plane (p>0.57 for all dose levels and 
comparisons). Consequently, the corresponding sensitometric curves are not 
included in figure 2.1. However, statistically significant OD changes occur 
when flipping the film upside down or rotating it 90° in the scan bed plane. A 
90° rotation in the scan bed plane (portrait versus landscape orientation) 
induces OD differences of 10.60% and 10.36% at 130 cGy for the Nikon and 
Epson scanner respectively (p < 4.5x10-19 for all dose levels and 
comparisons). Smaller variations are found when flipping the film upside 
down. In this case, optical densities differ by only 1.95% and 1.10% at 130 
cGy at the Nikon and Epson scanner respectively (landscape versus landscape 
flipped, p < 0.043 for all dose levels and comparisons). 
Film sensitivity, defined as the net OD change per unit of absorbed dose, 
is approximately twice as large for the Nikon scanner as for the Epson scanner 
(for all dose levels and film orientations). As can be seen in figure 2.1, the 
highest scanner sensitivity is found for both scanners when scanning the film 
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in portrait orientation. Scanner sensitivity then amounts to 0.002444/cGy and 
0.001018/cGy at 130 cGy for the Nikon and Epson scanner respectively. For 
this reason, the portrait orientation is used in all following experiments. 
 
 
Figure 2.1: Sensitometric curves for Gafchromic EBT2 film scanned in different 
orientations on the Epson Expression 10000XL and the Nikon Coolscan 9000ED 
transmission scanners. A third-order polynomial fit to the data is shown. Error flags, 
representing the standard deviation of the mean (σ/√n) in the considered ROI, are 
smaller than the marker sizes. 
 
2.3.2. Local response fluctuations  
Figure 2.2 (a) presents the relative OD uncertainties associated with local OD 
variations, as a function of scanning resolution and absorbed dose. For the 
considered dose range, relative uncertainties in optical density generally rise 
with increasing resolution and decreasing dose. However, while OD 
uncertainties are similar for both scanners at a resolution of 100 dpi, their rise 
with increasing resolution is the most pronounced for the Nikon scanner. As 
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a consequence, OD uncertainty on the Nikon scanner exceeds the values for 
the Epson scanner. At a resolution of 800 dpi, OD uncertainty amounts to 
1.84% at 130 cGy for the Nikon scanner, compared to an uncertainty of 1.28% 
for the Epson scanner. 
 
More relevant than OD uncertainties in themselves are their contributions to 
dose uncertainty. For a given type of radiochromic film, this conversion 
depends on the slope of the sensitometric curve, and thus on the digitizer used. 
Due to the high sensitivity of the Nikon scanner, small variations in absorbed 
dose are associated with large differences in OD. Accordingly, a given 
variation in OD corresponds to a smaller variation in absorbed dose on the 
Nikon scanner compared to the Epson scanner. Consequently, figure 2.2 (b) 
shows that, while OD uncertainties are similar for both scanners at 100 dpi, 
equivalent dose uncertainties are considerably lower for the Nikon scanner. 
This effect is particularly notable at low doses. At 29 cGy, dose uncertainty 
amounts to 3.43% for the Nikon scanner versus 5.25% for the Epson scanner. 
When scanning at higher resolutions, the high sensitivity of the Nikon scanner 
fails to compensate for its high OD uncertainty values. The Nikon scanner's 
dose uncertainty consequently exceeds the values for the Epson scanner, 
rising to 8.97% for the Nikon scanner versus 7.45% for the Epson scanner at 
29 cGy and 2400 dpi.  
 
A comparison of figures 2.2 (a) and 2.2 (b) further demonstrates that, 
depending on the dose level, OD uncertainties are converted into two- to four-
fold larger equivalent dose uncertainties. 
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Figure 2.2: Uncertainties associated with the scanning process of EBT2, in terms of 
optical density (a) and dose (b), as a function of absorbed dose, for the Epson 
Expression 10000XL and the Nikon Coolscan 9000 ED transmission scanners. The 
lines are drawn only to guide the eye. 
2.3.3. Scanner response uniformity 
The OD read-out uniformity of the Nikon scanner is assessed by scanning 
uniformly irradiated EBT2 film pieces. Figure 2.3 presents normalized OD 
variations across (a) and along the scan direction (b) through the centre of the 
reading area. The data points reflect mean optical densities in a ROI,  1.27 
mm wide across the scan direction and 16 mm along the scan direction. This 
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geometry permits the most accurate determination of the response uniformity 
in the direction in which the greatest variation is expected. 
 
 
Figure 2.3: Normalized OD variations across (a) and along (b) the scan direction in 
the center of the reading area for uniformly irradiated EBT2 film pieces scanned in 
the Nikon Coolscan 9000 ED transmission scanner. Error flags, representing the 
standard deviation of the mean (σ/√n) in the considered ROI, are smaller than the 
marker size. 
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As can be seen in figure 2.3 (a), the Nikon scanner’s relative response varies 
greatly in the direction of the CCD sensor, with optical densities increasing 
non-monotonically towards the edges of the reading area. The largest 
variations are found for the lowest optical densities: a maximum OD variation 
of 12.45%, over a distance of only 26.67 mm, is observed for the unirradiated 
EBT2 film pieces. In terms of absorbed dose, this corresponds to a variation 
of 34.4% and 6.2% at absorbed dose levels of 29 and 397 cGy. For 
comparison, preliminary research on the Epson scanner demonstrated an OD 
variation in the CCD-direction of 8.43% over a much larger distance of 26 
cm. Absorbed dose on the Epson scanner varies by 28.2% and 11.8% at 
absorbed dose levels of 29 and 397 cGy respectively. 
Optical densities vary to a lesser extent in the scan direction, a tendency 
repeatedly reported for other CCD-based transmission scanners (Martisikova 
et al., 2008; Fuss et al., 2007; Paelinck et al., 2007; Richley et al., 2010; 
Ferreira et al., 2009). For the Nikon scanner, the difference between the 
maximum and minimum OD in the scan direction is only 1.85% 
(figure 2.3 (b)). 
 
2.3.4. Drift and warm-up effects 
The results of the warm-up and drift effect experiment on the Nikon scanner 
are depicted in figure 2.4. As we do not expect the transmission spectrum of 
the step wedge to change with temperature, we hypothesize the OD wedge's 
relative response to reflect the stability of scanner properties, such as the light 
output or the detector's sensitivity.  
 
As can be seen in figure 2.4, the OD response shows a limited drift when 
inter-scan calibration is not performed (series 1): 100 consecutive scans raise 
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the step wedge's OD by 0.39% at OD level 0.72.  The maximum OD variation 
of 1.13% occurs for the lowest OD of 0.24. As expected, performing inter-
scan calibration (series 2 and 3) eliminates this drift and stabilizes the step 
wedge's OD response within 0.28% for all measured ODs (0.24 – 1.17).  The 
Epson scanner on the contrary, demonstrates an OD drift of 1.5% for the 
lowest optical densities, even with automatic calibration between the scans. 
These results suggest that the Nikon scanner's optics have an excellent 
stability compared to the Epson scanner.  
Moreover, the  stability of the step wedge's relative response at the start of 
series 3 suggests that the Nikon optics do not show any notable warm-up 
effects the way fluorescent lamps do. 
 
 
Figure 2.4: Normalized optical densities during the drift and warm-up experiment on 
the Nikon Coolscan 9000 ED transmission scanner. Normalization is performed 
relative to the optical density at the start of series 1. Error flags, representing the 
standard deviation of the mean (σ/√n) in the considered ROI, are smaller than the 
marker sizes. 
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Potential heating effects of the film inside the scanner are expected to be the 
most pronounced in scan series 1, as there are no calibration intervals, taking 
approximately 2 minutes, during which the film can cool down. Note, 
however, that the OD drift in scan series 1 originates from a combination of 
film temperature and scanner drift effects. However, the relative optical 
density after calibration at the end of series 1 remains a good estimate for 
residual effects of film temperature on OD read-out. Accordingly, 100 
subsequent scans result in an OD decrease of 0.44%, 0.63%, 0.61% and 
0.65% for films irradiated to an absorbed dose of 0, 71, 204 and 403 cGy 
respectively. In contrast, one hundred subsequent scans on the Epson scanner 
raise the flat-bed temperature by 3.5°C, resulting in a maximum OD increase 
of 1.5% for the same OD range. 
Interestingly, the 40 scans in scan series 3, that are separated by 2-minute 
calibration intervals, induce OD alterations on the same order as the residual 
changes after the calibration at the end of series 1. Optical densities then 
decrease by 0.63%, 0.49%, 0.40% and 0.35% for films irradiated to 0, 71, 204 
and 403 cGy. For this reason, we hypothesize that this small effect is not 
caused by direct heating of the film by the LED light sources, but by a slow 
adaptation of the film temperature to the scanner’s internal environment, 
which might be gradually heated by the scanning system’s motors. 
Accordingly, no such temperature changes are observed in scan series 2, as 
the film has been positioned in the scanner for about 1.5 hour during scan 
series 1.  
Unexpectedly, the small residual OD decrease of approximately 0.5% at 
the end of series 2 is not neutralized after the 1-hour cooling interval. This 
small effect might also be related to the scanner's internal temperature, as the 
film had been positioned in the scanner for more than 2 minutes at the start of 
series 3. The scanner's internal temperature varies with room temperature and 
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might have increased during the 1-hour cooling interval, since the scanner 
remained turned on during the complete procedure. 
 
2.3.5. Overall performance 
As demonstrated in figure 2.5, the absolute dose build-up measured by the 
EBT2-Nikon scanner combination is in good agreement with the plane-
parallel chamber measurements: the maximum dose difference amounts to 
only 1.55% 9.  
Equally, the gamma evaluation for the 6MV IMRT-beam demonstrates 
good agreement between measured and calculated data (figure 2.6). The 
fraction of data points resulting in a gamma index smaller than one amounts 
to 97.37%, thus illustrating the potential of the EBT2-Nikon scanner 
combination for two-dimensional dose verification. 
As expected, no moiré-patterns are detected in any of the digitized images. 
In agreement with previous experience with this EBT2 film lot, we did not 
observe significant disturbances in the dose distribution related to film 
response inhomogeneities.  
 
  
                                                     
9 As a reference for comparison, a similar analysis was performed for digitization of 
the films on the Epson 10000XL scanner. All parameters and precautions 
implemented in the Nikon digitization protocol (see Section 2.2.3.5) were equally 
applied for digitization on the Epson scanner. Additionally, films were scanned 6 
times prior to data-acquisition, in order to minimize the influence of the Epson 
scanner’s warm-up effects. The maximum dose difference between film and plane-
parallel chamber measurements was 1.55% for digitization on the Nikon scanner 
versus 2.55% for the Epson scanner. The mean dose difference (between 2 and 
15 mm depth) between the film and chamber measurements was 0.81% versus 1.24% 
for the Nikon versus Epson scanner. 
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Figure 2.5: Absorbed dose build-up in a 6MV photon beam measured by a Markus 
plane parallel chamber and EBT2 radiochromic film digitized on the Nikon Coolscan 
9000ED scanner. Error flags represent the standard deviation of the mean (σ/√n) for 
3 repeated measurements. Error flags for the Markus chamber measurements are 
smaller than the marker sizes. No normalization was applied to the measurements. 
 
2.4. Discussion 
The examination of the Nikon Coolscan 9000ED transmission scanner 
identified some qualities essential to high-gradient dosimetry, as well as some 
artefacts commonly observed in CCD-based transmission scanners. The 
aggregate of characteristics affects measurement accuracy and the dosimetric 
protocol's complexity in various ways.  
 
Particularly important is the superior sensitivity of the Nikon scanner for 
radiochromic film dosimetry: it is found to be approximately twice as high as 
for the Epson Expression 10000XL scanner, which is recommended by the 
EBT2 manufacturer and widely used for radiochromic film dosimetry. Even 
though no information is available on the Nikon's light source emission 
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spectrum, its high sensitivity is most probably due to the good conformity of 
the major peak in the EBT2 absorption spectrum (636 nm) and the red LED's 
emission spectrum. For a given absorbed dose distribution, such a high 
sensitivity, combined with a broad dynamic range, results in more contrast in 
the digitized image.  
Additionally, the high scanner sensitivity of the Nikon scanner has a 
considerable impact on dose uncertainties associated with local optical 
density variations, arising from, for instance, electronic scanner noise. For an 
optical resolution of 100 dpi, uncertainties in terms of dose associated with 
those local OD variations are considerably lower on the Nikon scanner 
compared to the Epson scanner. For both scanners, OD and dose uncertainties 
rise to unacceptably high levels when scanning at higher resolutions of 800 
or 2400 dpi. Note, however, that these reported uncertainty values do not 
reflect global measurement uncertainties. On the contrary, they are merely 
meant as a measure for the contribution of local OD variations to overall 
uncertainty. A more comprehensive description of global measurement 
uncertainties in radiochromic film dosimetry is given in (Bouchard et al., 
2009). 
The current results also highlight the need for a consistent orientation of 
radiochromic film on transmission scanners. In literature, large OD 
differences of up to 15% are reported when rotating EBT or EBT2 type film 
90° in the scan bed plane (Zeidan et al., 2006; Lynch et al., 2006; Aldelaijan 
et al., 2010). These findings are consistent with the present results on the 
Epson scanner, while similar results are found on the Nikon scanner. 
Interestingly, one major difference between our results and previous studies 
(Aldelaijan et al., 2010; Desroches et al., 2010) did emerge.  
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Figure 2.6: The absorbed dose distribution in a 6 MV IMRT- beam as calculated by 
the analytical anisotropic algorithm implemented in the Eclipse treatment planning 
system (a) and as measured by the EBT2- Nikon scanner combination (b). The 
corresponding gamma-histogram (c) represents the normalized frequency of gamma 
indices for tolerance levels 3% - 3mm. 
Desroches et al. (2010) found the OD alterations, on the order of 1%, when 
scanning EBT2 radiochromic film on alternate sides on the Epson Expression 
10000XL not to be statistically significant. Even though the current results 
agree on the magnitude of the differences, they were found in this study to be 
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statistically significant for both the Epson and the Nikon scanner. We 
hypothesize that this effect arises from the combination of polarization effects 
and the film's asymmetrical structure. 
Moreover, our experiments confirm that the red LED light source in the 
Nikon scanner does not require any warm-up scans prior to data acquisition. 
They also demonstrate the excellent stability of the Nikon scanner’s optics, 
as long as scanner calibration is regularly performed. In this study, scanner 
calibration is performed between each successive scan. Our experiments 
suggest, however, that one scanner calibration every 20 scans might suffice 
for practical dosimetry protocols. Furthermore, we found limited effects of 
temperature changes of the film inside the scanner. When scanning the film 
100 consecutive times without inter-scan calibration or 40 times with inter-
scan calibration, optical densities are found constant within 0.75%, 
eliminating the need for monitoring and management of the film temperature 
inside the scanner.  
Scanner response, however, was found to vary considerably across the 
Nikon scanner’s reading area, especially in the CCD-direction. As a similar 
pattern is observed when scanning radiographic film, this effect cannot be 
uniquely attributed to polarization effects. Other factors, such as a varying 
detector sensitivity along the detector array direction, might be involved 
(Devic et al., 2006b). These non-uniformities require an OD-dependent 
correction procedure to be incorporated into the dosimetric protocol. 
This relatively uncomplicated dosimetric protocol, without warm-up scans 
nor temperature monitoring, resulted in accurate measurements of the 
absorbed dose build-up in a 6 MV photon beam and demonstrated its potential 
for two-dimensional dose verification in high-gradient dosimetry. These 
experiments also illustrated the major advantage of the Nikon scanner over 
the commonly used flatbed scanners: the absence of the glass plate for film 
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positioning eliminated OD disturbances by moiré-patterns in all digitized 
images. 
One of the major limitations of the Nikon Coolscan transmission scanner, 
however, is related to film size: it accommodates films up to 6.2 x 20 cm². As 
a consequence, the Nikon scanner is not an appropriate choice for quality 
assurance of clinical treatment plans, for which large films are generally 
required. Due to its excellent characteristics, it remains, however, the 
preferential choice for many other applications that may be limited to small 
film sizes, such as dosimetry in the build-up region. 
2.5. Conclusion 
The Nikon Coolscan 9000ED transmission scanner exhibits multiple qualities 
essential to high-gradient radiochromic film dosimetry. Particularly important 
is its high sensitivity, resulting in more contrast in the digitized image. The 
scanner's optics also demonstrated an excellent stability and did not 
necessitate warm-up scans prior to data-acquisition. Moreover, effects of 
temperature changes of the film inside the scanner were shown to be limited, 
rendering temperature monitoring of the film inside the scanner redundant. 
Its main advantage, however, is the absence of a glass plate for film 
positioning, thereby limiting OD disturbances by moiré-patterns. On the other 
hand, scanner response was shown to vary considerably across the reading 
area, requiring an OD-dependent correction procedure to be incorporated into 
the digitizing protocol. The main limitation of the Nikon Coolscan 9000ED 
transmission scanner remains, however, its film size restriction to 6.2 x 20 
cm². Nevertheless, its excellent characteristics render it the preferential tool 
for high-gradient radiochromic film dosimetry in applications limited to small 
film sizes, such as dosimetry in the build-up region. 
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Abstract 
This study evaluated absorbed dose measurement and calculation accuracy in 
the build-up region of conventional (FF) versus flattening filter-free (FFF) 
photon beams. The absorbed dose in the build-up region of 6 and 10 MV FF 
and FFF beams was measured using radiochromic film and extrapolation 
chamber dosimetry for single beams with a variety of field sizes, shapes and 
positions relative to the central axis. For the 10 MV single beams, build-up 
dose calculation accuracy of the XVMC code in the Monaco treatment 
planning system was evaluated. Removing the flattening filter generally 
resulted in slightly higher build-up doses. No considerable impact on the 
depth of maximum dose was found. Regarding calculation accuracy, our 
study detected small but statistically significant improvements in mean 
gamma-value (1% - 1mm and 3% - 3mm), dose difference and distance-to-
agreement for the unflattened compared to the flattened calculation model. 
Similar results were found for two more complex FF and FFF IMRT 
treatment plans. Generally, considerable differences between measurements 
and calculations were detected in the build-up region of both FF and FFF 
beams, but small improvements were found when using FFF beams. 
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3.1. Introduction 
As modern intensity modulated radiation techniques (IMRT) do not require a 
uniform photon fluence across the beam, multiple authors have investigated 
the advantages when operating linear accelerators without a flattening filter. 
In literature, the main rationale behind the removal of the flattening filter 
concerns an increase in dose rate (Fu et al., 2004; Vassiliev et al., 2006b; 
Dalaryd et al., 2010; Najem et al., 2014; Xiao, 2015) and an important 
reduction of the head scatter and its variation with field size (Vassiliev et al., 
2006b; Kragl et al., 2009; Najem et al., 2014). As a result, the use of flattening 
filter-free (FFF) photon beams in IMRT has been shown to reduce out-of-
field dose (Kragl et al., 2011b; Kry et al., 2010; Xiao, 2015) and delivery 
times while maintaining treatment plan quality (Lechner et al., 2013). 
However, as the flattening filter is generally considered the main source 
of electron contamination and strongly influences the low-energy 
contributions of the beam spectrum (Mesbahi, 2007; Tsechanski et al., 2005; 
Dalaryd et al., 2010), flattening filter removal is also expected to affect the 
absorbed dose in the build-up region of megavoltage photon beams. In 
literature, however, no detailed study on the build-up dose in conventional 
(FF) versus flattening filter-free beams is available. While some authors 
shortly addressed build-up dose when investigating the advantages of FFF 
beams, these studies remained limited to the central axis and mostly included 
centrally positioned fields (Kragl et al., 2009; Vassiliev et al., 2006b; Wang 
et al., 2012; Cashmore, 2008; Najem et al., 2014). Additionally, most of these 
data rely on fixed separation plane-parallel chamber measurements. When 
used in the build-up region, these chambers suffer from multiple limitations, 
such as the finite entrance window thickness, possible polarity effects and 
uncertainties regarding the stopping-power ratio (Almond et al., 1997). 
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Within these limitations, the studies reported FFF surface dose to be slightly 
higher for small fields (Kragl et al., 2009; Cashmore, 2008; Vassiliev et al., 
2006b; Wang et al., 2012; Najem et al., 2014), but similar or lower for large 
fields (Vassiliev et al., 2006b; Kragl et al., 2009). For the older generation of 
FFF accelerators without multileaf collimator (MLC), Sixel et al. (1994) 
reported the depth of dose maximum for large FFF beams to be constant with 
field size, while a gradual decrease with field size was observed for FF beams. 
In this respect, the first part of this study aims at quantifying the absorbed 
dose in the build-up region for a broad range of investigated depths and 
measurement positions within each field, for a variety of field sizes and field 
positions relative to the central axis. To cope with the mentioned 
measurement uncertainties, a combination of radiochromic film and 
extrapolation chamber dosimetry was used. 
Additionally, removing the flattening filter is often suggested to enhance 
dose calculation accuracy in the build-up region, as modern treatment 
planning systems (TPS) still rely on simple models for electron contamination 
and large amounts of head scatter further complicate calculations (Cashmore, 
2008; Georg et al., 2011). The currently available literature, however, lacks 
data supporting or rejecting this hypothesis. To our knowledge, only Kragl et 
al. (2011a) assessed calculation accuracy at 1 cm depth for the enhanced 
collapsed cone (eCC) algorithm implemented in Oncentra Masterplan and the 
XVMC code in Monaco. At this depth, both algorithms were found to perform 
better for FFF beams, reaching statistical significance for the eCC algorithm 
only. In this respect, our study now evaluates dose calculation accuracy for 
the XVMC code in Monaco at multiple depths and positions for a variety of 
field sizes and field positions relative to the central axis. 
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3.2. Materials and Methods 
3.2.1. Absorbed dose measurements 
3.2.1.1. Linear accelerator  
All beams were provided by an Elekta Precise linear accelerator, equipped 
with an Elekta MLCi multileaf collimator (Elekta, Crawley, West-Sussex, 
UK). In order to guarantee the normal operation of the monitor chamber and 
beam steering in flattening filter-free mode, a 2 mm steel disk is standardly 
positioned in the filter carousel and inserted in the beam line in FFF mode. 
Measurements were performed in both 6 MV energy-matched and 10 MV 
non-matched beams. While the energy-matched beams have a comparable 
quality index (TPR20/10: 0.686 (FF) and 0.684 (FFF)), the non-matched beams 
employ the same electron energy incident on the target (TPR20/10: 0.735 (FF) 
and 0.714 (FFF) (Kragl et al., 2009). The gantry and collimator angles were 
always 90° and 0° respectively. SSD was always set to 90 cm. 
 
3.2.1.2. Investigated fields  
Our evaluation included 5x5, 10x10, 15x15, 20x5 and 20x10 cm² fields 
positioned symmetrically on, 5 and 10 cm off the central axis in the leaf travel 
direction. For the elongated fields, the longest field dimension was 
perpendicular to the leaf travel direction. 
3.2.1.3. Dosimetric techniques  
Measurements were mainly conducted by radiochromic film dosimetry 
(Gafchromic EBT2, Ashland Specialty Ingredients, USA). Additionally, 
extrapolation chamber measurements (EPC, Böhm type 23392, PTW-
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Freiburg, Germany) were performed for the large, centrally positioned fields. 
Figure 3.1 provides an overview of both the film and EPC experimental 
set-up. 
Figure 3.1: Schematic representation of the extrapolation chamber (a) and film 
dosimetry (b-c) set-up. Build-up dose was measured by positioning Solid Water slabs 
in front of the extrapolation chamber's entrance window, while the SSD was kept 
constant by lateral table readjustments (a). Two radiochromic films were mounted in 
parallel orientation in a Solid Water slab phantom (b-c). Subplots (b) and (c) represent 
the phantom set-up for a central and an elongated off-axis field respectively. The red 
stars mark the positions in the films where PDDs have been extracted. ? represents 
the distance in the latero-lateral direction between the PDDs extracted in one film. 
Radiochromic films were scanned prior to and 36 hours after irradiation on 
an Epson Expression 1680 Pro flatbed scanner in transmission mode (Seiko 
Epson Corp., Japan). The net optical density in the red colour channel was 
used for film calibration. An extensive description of the film scanning 
protocol is provided in (Fuss et al., 2007). The films were irradiated in a 
parallel orientation in a 30x30x30 cm³ horizontally stacked Solid Water 
phantom (type 457, Gammex Inc., USA). Overestimation of the dose in films 
containing the central axis was avoided by positioning these films at a 
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distance of 0.5 cm from the central axis (Suchowerska et al., 2001). For the 
centrally positioned fields, a first film (the central film) was thus positioned 
0.5 cm above the beam's central axis. For the off-axis fields, this central film 
was positioned in a horizontal plane through the intersection of the beam's 
central ray and the phantom surface. As illustrated further in figure 3.1 (b-c), 
a second film was positioned in a horizontal plane at a distance of 1.5, 2.5, 
5.5, 1.5 and 2.5 cm above the central axis (or the intersection of the central 
ray and the phantom surface for the off-axis fields)  for the 5x5, 10x10, 15x15, 
20x5 and 20x10 cm² fields respectively. All film measurements were repeated 
completely three times 10. 
For the 10x10, 15x15 and 20x10 cm² centrally positioned fields, relative 
dose measurements at (0.5 cm above) the central axis were extended to 
shallower depths (0.0075 mm) by using a Böhm extrapolation chamber. The 
chamber's large collecting electrode (3 cm diameter) does not allow 
applications in lateral dose gradients or smaller fields. In this respect, the 
beam commissioning data at 15 mm depth of both 10x10 and 20x20 cm² FF 
and FFF fields demonstrated the homogeneity across the collecting electrode 
to be within 2.5%. As shown in figure 3.1 (a), the chamber was mounted 
horizontally on a vertical stand, thus allowing for the acquisition of depth-
ionization profiles by successively adding Solid Water slabs in front of the 
chamber's entrance window. The SSD was then kept constant by lateral table 
readjustments 11. The electrode separations were 0.5, 1 and 2 mm. The electric 
field strength equalled 200 V/mm. These settings were found to guarantee the 
                                                     
10 Per beam (6MV FF, 6MV FFF, 10MV FF and 10MV FFF), the measurement 
repetitions for the radiochromic film were performed on the same day. 
11 In order to test the reproducibility of this approach, the relative dose at 1 mm depth 
in a 6MV FF beam was measured 10 times after complete repositioning of the 
extrapolation chamber and phantom slab in the lateral direction. The relative doses at 
1 mm depth after repositioning in the lateral direction agreed within 0.69%. 
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chamber's operation within saturation condition (within 1%) for all beams. 
Measurements were performed at 0.0075, 2 and 5 mm depth and the estimated 
depth of the dose maximum (15 and 20 mm for 6 and 10 MV respectively). 
All extrapolation chamber measurements were repeated twice 12. 
3.2.1.4. Data analysis and normalization  
In order to obtain a relevant comparison between the FF and FFF beams, all 
measured doses were normalized to the dose delivered locally at a reference 
depth of 10 cm (in the same horizontal film plane). Within each film, two 
percentage depth doses (PDDs) were extracted perpendicular to the phantom 
surface. As illustrated in figure 3.1 (b-c), a first PDD was extracted in the 
latero-lateral centre of the field. For the 5x5, 10x10, 15x15, 20x5 and 20x10 
cm² fields respectively, the second PDD was extracted in the same film at a 
distance ??? equalling 1.5, 2.5, 5.5, 5 and 5 cm from the first PDD in the 
direction perpendicular to the leaf travel direction (figure 3.1). The PDD 
extracted at the centre of the central film is further referred to as the central 
PDD. 
 
3.2.2. Dose calculation accuracy 
3.2.2.1. Calculation parameters  
Calculations were executed with the XVMC Monte Carlo code implemented 
in the Monaco treatment planning system (version 3.2., Elekta CMS 
Software). The FF and FFF beam models were created with the virtual source 
                                                     
12 Per beam (6MV FF, 6MV FFF, 10MV FF and 10MV FFF), the measurement 
repetitions for the extrapolation chamber were performed on the same day. 
Extrapolation chamber measurements were not performed on the same day as the film 
measurements. 
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model (VSM) version 1.6 13.  The Monte Carlo variance setting was 1% and 
a dose grid resolution of 1 mm was used.  
3.2.2.2. Single beam test 
All measured 10 MV PDDs were compared to the calculated PDDs by 
evaluating the dose discrepancy, distance-to-agreement and gamma-values. 
In contrast to the comparison of the measured FF versus FFF data, all 
measured and calculated PDDs were now normalized to the absorbed dose at 
10 cm depth in the central PDD. For the gamma-analysis, tolerance levels of 
1mm - 1% of the local dose and 3 mm - 3% of the local dose were employed. 
Due to the dose grid resolution of 1 mm, the analysis was restricted to depths 
beyond 1 mm. The largest depth considered was 23.5 mm (105% of the depth 
of the average dose maximum). A pair-wise comparison of the dose-
differences, distances-to-agreement and gamma-values of the FF versus the 
corresponding FFF beams was performed. As these data were not normally 
distributed, a non-parametric test was used. The statistical significance of 
these differences was determined using a Wilcoxon signed rank test (5% 
significance level, non parametric test, pair-wise comparison) using SPSS 
Statistics (version 22, IBM Corp., USA). 
3.2.2.3. IMRT treatment plans 
Dose calculation accuracy at shallow depths was investigated for more 
complex, clinically relevant FF and FFF IMRT plans comprising different 
field sizes. The purpose of this experiment was to evaluate calculation 
accuracy for more complex FF and FFF plans, rather than to compare the 
absorbed doses in the build-up region itself. To that purpose, we used an 
                                                     
13 In accordance with the company policy, all beam models were created by the 
treatment planning system company (Elekta CMS Software). 
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IMRT FF and FFF treatment plan pair for a randomly selected prostate case 
with simultaneous irradiation of the lymph nodes (large treatment volume) 
and a separate boost plan pair (small treatment volume). As such, we studied 
FF versus FFF plan pairs consisting of both small and large segments (the 
large treatment volume plans) and consisting of small segments uniquely 
(small treatment volume plans). As the FF and FFF plan pairs were created 
using the same plan prescriptions (i.e. cost functions), they complied to the 
same prescribed objectives and constraints. The large treatment volume FF 
and FFF plans consisted of 9 beams with gantry angles between 20° and 340° 
degrees, while the small treatment volume FF and FFF plans consisted of 5 
beams with gantry angles between 36° and 324°. However, in order to 
combine the build-up of all beams in one region, all beams' gantry angles 
were set to 90°. Dose measurements were equally performed using 
radiochromic film in a parallel orientation, 0.5 cm above the central axis in 
the 30x30x30 cm³ Solid Water phantom. A 2D-gamma analysis with 
tolerance levels equalling 1 mm - 1% of the local dose and 3 mm - 3% of the 
local dose was performed. The statistical significance of gamma-differences 
between FF and FFF beams was evaluated. As for the single beam tests, the 
data were not normally distributed and a non-parametric test was used. 
However, as a combination of different fields was studied in the FF and FFF 
IMRT cases, a paired comparison would be inappropriate. For these reasons, 
a Mann-Whitney U test with a significance level of 5% was employed. 
Gamma values in the penumbral regions or outside the build-up region (1 to 
23.5 mm) were excluded from this analysis. 
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3.3. Results 
3.3.1. Absorbed dose measurements 
Figure 3.2 demonstrates both film and extrapolation chamber measurements 
for the 10 MV centrally positioned large fields. These data clearly illustrate 
excellent agreement between film and extrapolation chamber data at all 
depths. Similar results were found for both energies. The mean dose 
difference and distance-to-agreement between film and extrapolation 
chamber measurements for all investigated beams and depths were 2.17% 14 
and 0.58 mm respectively.  
Figure 3.2 also demonstrates the FFF beams to have similar to slightly higher 
build-up doses compared to conventional beams, a trend generally observed 
for both energies and all field sizes. In this respect, table 3.1 provides detailed 
information on the PDDs of the centrally positioned fields at 1 and 5 mm 
depth for the central and one off-axis PDD. For these fields, the dose increase 
in FFF compared to FF beams at 1 mm depth varied between to -2.9 ±  4.7% 
to 15.0 ± 3.5% (6 MV) or 4.9 ± 6.4% to 14.6 ± 2.7% (10 MV) depending on 
the field size and position within the field. These observed differences tend to 
decrease with increasing depth and were less pronounced for the off-axis 
fields. Note, however, that these off-axis field data require careful 
interpretation, as the PDDs' orientation did not follow the beam's divergence 
15. 
Remarkably, extrapolation chamber data for the large fields suggest the 
dose differences between FF and FFF beams to become much smaller at 
shallower depths (figure 3.2 (d)). At 0.0075 mm depth, the dose difference 
                                                     
14 The dose difference was calculated with the local dose as a reference. 
15 For the off-axis fields, the beam divergence might result in a lower normalization 
dose (the local dose at 10 cm depth). 
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between FF and FFF beams varied between only 0.06 ± 0.03% and 2.19 ± 
0.02% depending on the field size and energy. 
 
Data shown in figure 3.2 and table 3.1 equally demonstrate the surface dose 
(at 1 mm depth) to increase with field size for both FF and FFF beams. For 
the centrally positioned square fields, a linear relationship between field side 
and dose at the central axis at 1 mm depth was detected for FF and FFF beams 
and both energies (figure 3.3). For the rectangular fields, the side of the 
equivalent square, which features the same area-to-perimeter ratio, was 
considered. The mean correlation coefficient, resulting from the square field 
points, for all centrally positioned square fields (6MV FF, 6MV FFF, 10MV 
FF, 10MV FFF) was 0.92, supporting the linear relationship. 
Overall, the linear relationship between superficial dose and field size 
deteriorated with increasing depth. Analysis of the depth of the dose 
maximum at the central axis of the centrally positioned fields did not show 
any consistent shift when comparing FF to FFF beams. 
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Figure 3.2 16: Central PDDs (normalized to the absorbed dose at 10 cm depth) for 
the 10MV centrally positioned 10x10 cm² (a), 15x15 cm² (b) and 10x20 cm² (c) FF 
and FFF fields as measured by radiochromic film and extrapolation chamber (EPC). 
Subplot (d) compares the fractional differences between FF and FFF beams at the 
shallowest depth (0.0075 mm). The error bars represent the standard deviation of the 
mean (??√?n) for three repeated film measurements. The error bars for the 
extrapolation chamber measurements are smaller than the marker size. 
                                                     
16 For subplots (c-d), see next page. 
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Figure 3.2 17: Central PDDs (normalized to the absorbed dose at 10 cm depth) for 
the 10MV centrally positioned 10x10 cm² (a), 15x15 cm² (b) and 10x20 cm² (c) FF 
and FFF fields as measured by radiochromic film and extrapolation chamber (EPC). 
Subplot (d) compares the fractional differences between FF and FFF beams at the 
shallowest depth (0.0075 mm). The error bars represent the standard deviation of the 
mean (??√?n) for three repeated film measurements. The error bars for the 
extrapolation chamber measurements are smaller than the marker size. 
17 For subplots (a-b), see previous page. 
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Table 3.1: PDDs and mean absolute differences (FFF-FF), as measured by film 
dosimetry, for the centrally positioned fields at 1 and 5 mm depth (normalized to the 
dose absorbed locally at 10 cm depth) for the central PDD  and the PDD positioned 
halfway the field dimension off the central axis (in the direction perpendicular to the 
leaf travel direction). The measures of variation represent the standard error of the 
mean (σ/√n) for 3 repeated measurements. 
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Figure 3.3: Absorbed dose (normalized to the absorbed dose at 10 cm depth) at 1 
mm depth along the central PDD for the centrally positioned fields (5x5, 
10x10,15x15, 20x5, 20x10 cm²) as a function of the side of the equivalent square 
field. The full markers represent the square fields, while the blank markers correspond 
to the 20x5 and 20x10 cm² fields. 
3.3.2. Dose calculation accuracy 
3.3.2.1. Single beam tests 
An overview of the gamma-values, dose differences and distances-to-
agreement (measured versus calculated PDDs) for the FF and FFF single 
beams is shown in table 3.2. These data demonstrate that, while measured and 
calculated build-up doses differ considerably for both FF and FFF beams, 
small but significant improvements in all evaluated parameters (gamma-
values, dose differences and distances-to-agreement) occur when removing 
the flattening filter. A pair-wise comparison of these flattened versus the 
unflattened parameters demonstrated the  ?mean-value to decrease significantly 
for the central fields (??????mm= 0.5, ??????mm= 0.2, p=0.02), the square fields 
(??????mm= 1, ??????mm= 0.3, p<0.001) and the off-axis PDDs (??????mm = 0.6, 
??????mm= 0.2, p=0.03). When considering smaller regions of the build-up 
region, the largest reduction of gamma-values was found at depths between 
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1 and 5 mm (??????mm = 2.22, ??????mm = 0.7, p<0.001). For the other depth 
regions and subgroups, no conclusions could be drawn based on the available 
data. 
 
Despite these improvements, considerable differences between measured and 
calculated build-up doses still occurred for both FF and FFF beams, mainly 
at the most shallow depths. At 1 mm depth on average, dose discrepancies 
amounted to 13.73% (FF) and 11.60% (FFF) when considering all PDDs. 
However, these differences decreased to only 3.62% (FF) and 2.92% (FFF) 
at the depth of the dose maximum. 
3.3.2.2. IMRT treatment plans 
Figures 3.4 and 3.5 provide an overview of the measured and calculated 
dose distributions and gamma histograms for the large and small treatment 
volume plans, respectively. As for the single beam tests, the FFF plans 
showed statistically significant improvements in gamma-values compared to 
the FF plans. For the 1% - 1 mm tolerance criteria, the mean gamma-value in 
the build-up region decreased from 1.64 (0.55 for 3% - 3mm) for the FF plan 
to 1.36 ( 0.45 for 3% - 3mm)  for the FFF plan (p <0.001, Mann-Whitney U 
test). These improvements in mean gamma-value were even more 
pronounced for the small treatment volume plans: a decrease from 2.06 and 
0.69  (FF) to 0.72 and 0.24 (FFF, p <0.001, Mann-Whitney U test) was noted 
for the 1% - 1 mm and 3% - 3 mm tolerance criteria respectively. 
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Table 3.2: Mean gamma-values (tolerance criteria: 1 mm - 1% of the local dose and 
3 mm - 3% of the local dose), dose discrepancies (DD) and distances-to-agreement 
(DTA), comparing film measurements and calculations, for various subsets of the 10 
MV PDDs extending over the complete build-up region or a sub region. The first 
column (n) represents the number of PDDs for which the gamma-values, dose 
differences and distances-to-agreement were pair-wisely compared in each subgroup. 
1 The p-values for the (1%-1mm) gamma analysis and (3%-3mm) gamma analysis 
are identical. - * Statistically significant for a 5% significance level (pair-wise 
comparison in Wilcoxon signed rank test) 
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Figure 3.4: The absorbed dose distribution (%, normalized to the dose at 10 cm depth 
at the central axis) for the FF (a,b) and FFF (c,d) plans for a large treatment volume 
as measured by EBT2 radiochromic film (a,c) and as calculated by the XVMC Monte 
Carlo code implemented in the TPS (b,d). All beam's gantry angles of the IMRT plans 
were set to 90°. The black horizontal lines in (a-d) mark the beam axis' position. The 
marker dots in the measured dose distributions (a,c) served for film positioning. The 
corresponding gamma-histograms represent the normalized frequency of gamma 
indices (1 mm - 1% of the local dose) in the build-up region (1 to 23.5 mm) of the FF 
(e) and FFF (f) plans respectively. 
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Figure 3.5: The measured (a, c) and calculated (b, d) dose distributions and gamma-
histograms (e, f) for the FF (a, b, e) and FFF (c, d, f) plans for the small treatment 
volume. Further details on the data collection are provided in the caption of figure 
3.4. 
FLATTENING   FILTER - FREE  LINEAR  ACCELERATORS  109 
 
3.4. Discussion 
When evaluating the absorbed dose in the build-up region of both FF and FFF 
beams, the use of an adequate detector is of major importance. The steep dose 
gradient and electronic disequilibrium in the build-up region require the 
detector to have a high spatial resolution combined with a low energy 
dependence. In this respect, the most commonly used detectors for build-up 
dosimetry include extrapolation and plane parallel ionization chambers, 
radiochromic film, TLDs, MOSFETs and diode detectors (O'Shea and 
McCavana, 2003). Extrapolation chamber dosimetry is generally considered 
the golden standard for build-up dose determination and was applied for the 
large centrally positioned fields. Note, however, that all ionization chamber 
measurements, including extrapolation chamber measurements, rely on the 
knowledge of the stopping-power-ratio for conversion of the measured depth-
ionization curves to depth-dose curves. While this ratio is known to be 
constant for depths beyond the depth of dose maximum, Andreo and Brahme 
(1986) showed that the Spencer-Attix stopping-power-ratio in the first few 
millimetres of megavoltage photon beams strongly depends on the presence 
of low energy photons and electrons in the beam. As a consequence, 
important variations of the stopping-power ratio in the first millimetres of the 
build-up region and between conventional and flattening filter free beams 
might be expected 18. For plane parallel chambers, beam perturbation, polarity 
effects and directional dependence would further complicate accurate dose 
determination (Gerbi and Khan, 1990, 1997, 1987).  
                                                     
18 The variability of the stopping-power ratios was not taken into account for any of 
our extrapolation chamber measurements, as this ratio depends on every detail of the 
beam spectra and would require the availability of detailed Monte-Carlo simulations 
and validated Monte-Carlo models of each beam investigated in this study. 
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In this study, extrapolation chamber measurements were complemented with 
radiochromic film dosimetry. Compared to the other detectors, its main 
advantages for build-up dosimetry include an excellent spatial resolution and 
very small energy dependence (Arjomandy et al., 2010). The obtained 
accuracy in radiochromic film dosimetry, however, does not uniquely depend 
on the quality of the film, but on the complete film-digitizer system and film 
scanning protocol. An extensive description of the film scanning protocol 
used is provided in (Fuss et al., 2007), while the precision and accuracy of 
the used film-digitizer system is extensively discussed in (Dreindl et al., 
2014). The most important aspects of the film-digitizer system and film 
scanning protocol contributing to type B uncertainties include the film 
scanning orientation, post-irradiation darkening and film uniformity. The 
applied scanning protocol eliminated any film orientation effects by scanning 
all films in a consistent orientation. Additionally, all films were scanned 
within 35 to 37 hours after irradiation. Based on the results reported by 
Dreindl et al. (2014), uncertainties associated with post-irradiation darkening 
are then expected to remain within 1% (of the net optical density) in the 
applied dose range (30-800 cGy). However, as all radiochromic film data 
have been normalized to the absorbed dose at 10 cm depth, the most important 
factor contributing to measurement uncertainty is the film uniformity. In this 
respect, the study by Dreindl et al. (2014) showed the local film uniformity 
in applied dose range (0-800cGy) to remain within 1.5%. 
In the first part of this study, the combination of both dosimetric techniques 
allowed us to confirm the qualitative trends previously reported on 
conventional versus FFF build-up dose (Kragl et al., 2009; Cashmore, 2008; 
Vassiliev et al., 2006a; Wang et al., 2012) and to extend these findings to a 
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wider range of field sizes, field positions and measurement positions within 
each field.  
Removing the flattening filter was found to slightly increase surface dose, 
but had no considerable effect on the depth of the dose maximum. As such, 
the findings of Sixel et al. (1994) on the depth of dose maximum for the older 
generation of FFF beams without MLC were not detected in this study. In the 
build-up region of megavoltage photon beams, these quantities all depend on 
the beam's x-ray spectrum and the presence of contaminating radiation. 
Removal of the flattening filter has been shown to eliminate its beam 
hardening effect, thus shifting the x-ray spectra to lower energies (Mesbahi 
and Nejad, 2008). Conversely, it is also expected to diminish the amount of 
contaminating radiation, as the flattening filter was identified as an important 
source of both electron contamination and head scatter (Chaney et al., 1994). 
As a consequence, the global effect of removing the flattening filter on the 
build-up dose depends on the balance of these competing factors. Our results 
clearly indicate that the impact of the shift of the x-ray spectrum is nearly 
compensated by the reduction of electron contamination and head scatter, 
thus merely resulting in a slight build-up dose increase. 
Particularly remarkable, however, are the extrapolation chamber results at 
the shallowest depth (0.0075 mm). These data suggest that differences in 
build-up dose between FF and FFF beams might become fractional at the 
surface, a tendency equally noted by Wang et al. (2012) for a slightly greater 
depth (0.03 mm). Note, however, that the measurements in both studies were 
performed by ionization chamber dosimetry. As previously mentioned, 
possible variations of the stopping-power-ratio in the first millimetres of the 
build-up and between conventional and flattening filter free beams might be 
expected. Whether the decreasing dose differences towards the surface in both 
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studies relate to these stopping-power-ratio uncertainties or truly reflect the 
physical reality, remains to be determined. 
 
Additionally, the second part of our study investigated if the altered spectrum 
of unflattened beams enhances dose calculation accuracy in the build-up 
region, as is often anticipated in literature due to the use of simple models for 
electron contamination and the large amounts of head scatter further 
complicating calculations in flattened beams (Georg et al., 2011; Cashmore, 
2008). In this respect, our study indeed detected statistically significant 
improvements in build-up dose calculation accuracy for the unflattened 
compared to the flattened calculation models. This tendency was the most 
pronounced at the shallowest depths and for PDDs acquired at off-axis 
positions within the considered field. The stronger improvements for the off-
axis PDDs have previously been reported for larger depths and can be 
ascribed to the reduction in off-axis softening of FFF beams compared to 
conventional beams (Kragl et al., 2011a; Georg et al., 2010). Note, however, 
that the calculation accuracy improvements were quite small and might have 
limited impact in the clinic. Differences in calculation accuracy of this order 
of magnitude might also result from small differences in tuning accuracy 
between the FF and FFF calculation models. 
Moreover, the positive impact of the altered spectral composition of 
unflattened beams might be limited by other factors negatively affecting dose 
calculation accuracy and thus contributing to the differences between 
calculations and radiochromic film measurements in this study. An important 
concern in this respect is the type of detector generally used for beam data 
collection. In Monaco, the parameters of the beam's virtual source model are 
tuned to measured PDDs. The treatment planning system manufacturer 
recommends these data to be collected with a waterproof scanning chamber 
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with a collection volume of approximately 0.125 cm³, such as the IBA CC13 
ionization chamber used in this study (sensitive volume diameter 6 mm and 
length 5.8 mm, volume 0.13 cm³, IBA-Dosimetry, Schwarzenbruck, 
Germany). For the general purpose of beam data collection, this type of 
chamber is recommended and very common in clinical practice. For several 
reasons, however, this detector is suboptimal for the very specific task of 
measuring build-up dose.  
Firstly, all ionization chambers might suffer from potential variations in 
stopping-power-ratio. For the large centrally positioned fields however, the 
agreement between our extrapolation chamber and film measurements (at 
depths beyond 1 mm) suggest the impact of variations in stopping-power-
ratios to remain small.  
Secondly, as recommended for thimble ionization chambers (Almond et 
al., 1999), the effective point of measurement of the detector was taken into 
account by shifting the measured data 0.6 times the cavity radius upstream. 
Kawrakow (2006), however, demonstrated that such a generic shift is 
inadequate in the build-up region, as the effective point of measurement 
depends on the beam quality, field size and specific details of the chamber 
design.  
A third important factor is the detector size and concomitant volume-
averaging effects. Even though the employed chamber is generally considered 
a small volume chamber, its volume averaging effect might become of major 
concern in the steep dose gradient of the build-up region. In this respect, Looe 
et al. (2013) demonstrated that volume averaging by this chamber could be 
modelled as a convolution of the 'true beam data', collected with a Si diode 
detector, with a Gaussian kernel with a standard deviation of 2.26 to 2.38 ± 
0.02 mm for 6 and 15 MV beams respectively. Yan et al. (2008) obtained 
similar results and, albeit for a different planning system, demonstrated a 
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gradual decrease in gamma-value passing rates in IMRT with increasing size 
of the detector used for collecting commissioning data.  
Considering these three factors, specific build-up dosimetry techniques, as 
mentioned in this manuscript, are mandatory for beam data collection. 
3.5. Conclusion 
Flattening filter free beams generally produced slightly higher build-up doses 
compared to conventional beams. In addition, our study clearly confirmed 
small but statistically significant improvements in calculation accuracy for 
the unflattened compared to the flattened beam model. Due to multiple factors 
negatively affecting build-up calculation accuracy of both flattened and 
unflattened beams, considerable differences between measurements and 
calculations persisted for both beam modalities. The assessment of the impact 
of unflattened beams on build-up dose calculation accuracy, however, 
requires refinements in build-up dose measurements in the process of beam 
commissioning for treatment planning. 
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Abstract 
Purpose. To assess the dosimetric impact of a patient positioning device for 
prone breast radiotherapy and assess the accuracy of a treatment planning 
system (TPS) in predicting this impact. 
Methods. Beam attenuation and build-up dose perturbations, mainly 
quantified by ionization chamber and radiochromic film dosimetry, were 
evaluated for 3 components of the patient positioning device: the carbon fiber 
baseplate, the support cushions and the support wedge for the contralateral 
breast. Dose calculations were performed using the XVMC dose engine 
implemented in the Monaco TPS. All components were included during 
acquisition of the planning CT data. 
Results. Beam attenuation amounted to 7.57% (6MV) and 5.33% (15MV) for 
beams obliquely intersecting the couchtop-baseplate combination. Beams 
traversing large sections of the support wedge were attenuated by 12.28% 
(6MV) and 9.37% (15MV). For the support cushion foam, beam attenuation 
remained limited to 0.11% (6MV) and 0.08% (15 MV) per centimeter 
thickness. A substantial loss of dose build-up was detected when irradiating 
through any of the investigated components. TPS dose calculations accurately 
predicted beam attenuation by the baseplate and support wedge. A manual 
density overwrite was needed to model attenuation by the support cushion 
foam. TPS dose calculations in build-up regions differed considerably from 
measurements for both open beams and beams traversing the AIO 
components. 
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Conclusions. Irradiating through the components of the positioning device 
resulted in a considerable degradation of skin sparing. Inclusion of the AIO 
components in the treatment planning CT allowed to accurately model the 
most important attenuation effect, but failed to precisely predict build-up 
doses. 
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4.1. Introduction 
Radiotherapy after breast-conserving surgery improves loco-regional control 
and survival. However, radiation induced cardiac events and cancer of the 
lungs and the non-treated breast are of increasing concern (Haviland et al., 
2013; Donovan et al., 2007; (EBCTCG), 2005, 2011). Recent studies provide 
evidence behind a shift to prone radiotherapy for breast cancer 19: less acute 
toxicity, less risk of radiation-induced cardiac toxicity and of lung cancer 
induction (Mulliez et al., 2013; Kirby et al., 2010; Mulliez et al., 2015). The 
prone set-up requires specific patient set-up devices. 
Although these positioning devices generally consist of low-density 
materials, a recent report by Olch et al. (2014)  emphasized that their 
dosimetric effects, including beam attenuation and build-up dose 
perturbations, can be clinically relevant, but are often underestimated or 
overlooked. Consequently, the authors stress the importance of taking these 
effects into account during the treatment planning process when beams 
traverse device components before entering the patient.  
In this respect, this study quantified the dosimetric impact of the 
widespread Orfit All-in-One Solution (AIO) patient positioning system (Orfit 
Industries, Wijnegem, Belgium) and assessed the accuracy of the Monaco 
treatment planning system (TPS) in modeling these effects. 
 
                                                     
19 Besides prone breast treatment, an alternative option to reduce the irradiated heart 
volume includes the use of deep-inspiration breath hold techniques (Yeung et al., 
2015). 
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4.2. Materials and Methods 
4.2.1. The positioning device 
The AIO device is an indexed patient positioning system that combines one 
carbon fiber baseplate with 4 sets of cushions and accessories into 4 different 
configurations. Each configuration is intended for a different treatment set-
up. This study mainly focused on the dosimetric properties of the system's 
generic components: the carbon fiber baseplate and support cushions. For the 
prone breast configuration (figure 4.1), the support wedge for the contralateral 
breast was also investigated. A detailed description of the prone breast 
configuration usage is provided in Mulliez et al. (2013). 
The carbon fiber baseplate (type 32301, figure 4.1 (b)) consists of a polyvinyl 
chloride foam core (0.07 g/cm³) sandwiched between two carbon fiber layers 
(thickness between 0.6 and 0.8 mm). It also contains some areas with 
excisions used for cushion positioning or with higher-density materials 
(1400 g/cm³) for reinforcement. The AIO support cushions consist of a low-
density polyethylene foam (0.029 g/cm³) with a thin polyurethane coating (> 
1000 g/cm³). The support wedge for the contralateral breast evenly consists 
of a foam core sandwiched between two carbon fiber layers.  
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Figure 4.1: The prone breast configuration (a) and baseplate (b) of the AIO 
positioning device (Courtesy of Orfit Industries). The positions of the cylindrical 
phantom and isocenter during the attenuation measurement (b) are indicated by the 
projection of the transversal and sagittal laser lines. The projection of the transversal 
and sagittal laser lines is depicted in green. Subplot (c) represents a transversal section 
through the baseplate and iBeam evo couchtop at the isocenter during the attenuation 
measurements. Subplot (d) presents a transversal section through the phantom set-up 
when measuring the dosimetric effects of the support wedge for the contralateral 
breast. The isocenter is represented by the projection of the sagittal and coronal laser 
lines. Subplot (e) represents a transversal CT slice through a patient on the prone 
breast set-up of the AIO device. Subplot (f) illustrates the experimental set-up when 
measuring the dosimetric effects of the support wedge for the contralateral breast. 
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4.2.2. Dosimetric effects 
4.2.2.1. Dosimetry techniques 
Beam attenuation was quantified by ionization chamber dosimetry (type 
30012, PTW Freiburg, Freiburg, Germany) as  the dose decrease at 10 cm 
depth in a polystyrene phantom (ρ=1.02 g/cm³) irradiated by a 10x10 cm² 
field. Build-up doses were measured by radiochromic film or extrapolation 
chamber using polystyrene slab phantoms. 
 
Radiochromic films 20 (Gafchromic EBT2, Ashland Specialty Ingredients, 
USA) were digitized on an Epson Expression 10000XL flatbed scanner with 
a resolution of 100 dpi and analyzed using the net optical density in the red 
color channel (Seiko Epson Corp., Japan) (De Puysseleyr et al., 2012). All 
radiochromic films were positioned in a transversal plane in parallel 
orientation relative to the beam axis. Measurement inaccuracies in films 
containing the central axis were avoided by positioning these films 0.5 cm off 
(cranial to) the central axis (Suchowerska et al., 2001). In order to avoid 
disturbances near the radiochromic film edge, data were only analyzed at a 
minimal depth of 1 mm. 
Extrapolation chamber measurements were performed using an 
extrapolation chamber (EPC, Böhm type 23392, PTW-Freiburg, Germany) 
with an entrance window thickness of 0.0075 mm. The used electrode 
separations and electric field strength were 0.5, 1 and 2 mm and 200 V/mm 
respectively. We preliminary showed that these settings guarantee the 
                                                     
20 The sensitometric curves for the radiochromic films were determined using a 
Farmer ionization chamber (type 30012, PTW Freiburg, Germany). The traceability 
to a primary standard was ensured by calibration of this chamber in a standard 
laboratory. 
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chamber's operation within saturation condition (1%) for all investigated 
beams. 
All investigations were conducted for 6 and 15 MV photon beams provided 
by an Elekta Synergy linear accelerator equipped with an MLCi2 multileaf 
collimator (MLC, Elekta, Crawley, West-Sussex, UK). 
4.2.2.2. The carbon fiber base plate 
As the carbon fiber baseplate is always to be mounted on a linac couchtop, it 
was always evaluated in conjunction with the iBeam evo couchtop (Medical 
Intelligence, Schwabmünchen, Germany) (Smith et al., 2010; Gerig et al., 
2010). All measurements were performed for this couchtop-baseplate 
combination as well as for the couchtop uniquely, serving as a reference for 
comparison. 
Beam attenuation by the baseplate and couchtop was determined as a function 
of gantry angle (between 90° and 270° at a 10° increment) at the center of a 
cylindrical polystyrene phantom (diameter 20 cm). This phantom was 
centered at the linac isocenter and at the lateral center of the couchtop or 
baseplate 21 (figure 4.1 (c)), which was checked using the sagittal lasers and 
the dosimetric techniques described by Olch et al. (2014). The position of the 
phantom in the longitudinal direction of the baseplate (figure 4.1 (b)) ensured 
the presence of both baseplate reinforcements and excisions in the beam. 
Attenuation was calculated as: 
???????????? ? ????? ? ?
???????
?????
?   (1) 
with D and Dopen representing the absorbed dose at the investigated gantry 
angle and the mean absorbed dose for the open fields (0°, 90° and 270°), 
                                                     
21 The phantom centre (in the lateral direction) was positioned at the centre of the 
table or baseplate on a lateral axis. 
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respectively. As we obtained excellent agreement between the attenuation 
values for gantry angles mirrored to the isocentric sagittal plane (for example 
100° and 260°) 22, these values were averaged.  
Build-up dose perturbations were measured using radiochromic films for 
5x5, 10x10 and 20x20 cm² fields with a gantry angle of 180° and for a 
10x10 cm² field with a gantry angle equaling 210°. The phantom was laterally 
centered on top of the couchtop or couchtop-baseplate combination. SSD 
was 100 cm.  
4.2.2.3. The support foam 
Beam attenuation by the support foam cushions was calculated with formula 
(1), with D and Dopen representing the absorbed dose with or without a foam 
sample (thickness between 5 and 15 cm) in the beam line on top of the 
phantom. SSD and field size were 90 cm and 10x10 cm², respectively.  
Build-up dose measurements were performed using radiochromic film 
dosimetry with and without the 10 cm thick foam sample in place. 
Radiochromic films were irradiated by 5x5, 10x10 and 20x20 cm² fields with 
a 90° gantry angle and by a 10x10 cm² field with a 60° gantry angle. SSD was 
100 cm. For the 10x10 cm² perpendicularly incident beam, build-up dose 
measurements were extended to shallower depths (0.0075 mm) using the 
Böhm EPC. This chamber was mounted horizontally on a vertical stand, thus 
allowing for the acquisition of depth-ionization profiles by successively 
adding polystyrene slabs in front of the chamber's entrance window. The SSD 
was then kept constant by lateral table readjustments. 
22 The attenuation values for the following gantry angles were averaged: 90° and 
270°, 100° and 260°, 110° and 250°, 120° and 240°, 130° and 230°, 140° and 220°, 
150° and 210°, 160° and 200°, 170° and 190°. 
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4.2.2.4. The support wedge 
As the support wedge is an accessory specific to the AIO prone breast 
configuration, its dosimetric effects have been investigated for a set-up 
geometry specific to this configuration (figure 4.1 (d-e)). A cylindrical 
polystyrene slab phantom (diameter 20 cm), representing the irradiated 
breast, and the support wedge for the contralateral breast were positioned in 
a low-density Styrofoam casing. The support wedge rested in a 0.5 cm-deep 
indentation in the polystyrene phantom, to model the contact between the 
wedge and pliable tissue of the irradiated breast. The absorbed dose in a 
transversal plane 0.5 cm off the central axis was measured by radiochromic 
film with and without the support wedge in place. Field size and gantry angle 
were 10x10 cm² and 280°, respectively. When considering all gantry angles 
clinically used during prone breast treatment, such a 280° beam intersects the 
largest portion of the support wedge and is consequently considered as the 
worst case scenario. 
 
4.2.3. Modeling in treatment planning system 
4.2.3.1. Calculation parameters 
All experiments were simulated using the XVMC Monte Carlo code 
implemented in the Monaco TPS (version 3.2., virtual source model 1.6, 
Elekta CMS Software). The dose grid resolution and variance settings were 3 
mm - 0.1% and 1.5 mm - 1% when simulating the attenuation and build-up 
experiments, respectively. The clinically available CT-to-RED (relative 
electron density) conversion table was used.  
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4.2.3.2. Modeling of the couchtop 
A contoured geometric model of the iBeam evo couchtop was created and 
stored in the Monaco TPS. Two contours were created on the couchtop CT 
images (slice thickness 1 mm): one representing the foam core and a second 
one lining the carbon fiber sandwich layers. An initial RED was assigned to 
each contour based on the electron densities and radiological path described 
by Smith et al. (2010). These values were subsequently optimized to match 
the measured attenuation values at multiple gantry angles. For the resulting 
contoured model, the calculated attenuation remained within 1.02% of the 
measured values for all gantry angles and beam energies.  The contoured 
model was incorporated into all CT images used for dose calculation. 
4.2.3.3. Modeling of the AIO Solution components 
CT images of all experimental set-ups were acquired on a large-bore CT 
scanner (Aquilion, Toshiba Medical Systems, Tokyo, Japan) with an extra 
large field-of-view (70 cm diameter) and a slice thickness of 1 mm. The 
acquired CT data, including the AIO component CT data, were used to 
calculate the dosimetric effects of the AIO baseplate and support wedge for 
the contralateral breast. For the support cushion foam, using the REDs 
obtained from the CT-to-RED conversion table did not affect the dose 
calculations for beams traversing 10 cm of foam. Therefore, artificial electron 
densities were manually assigned to the support cushions and were optimized 
in order to match the calculated attenuation values to the measured ones. 
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4.3. Results 
4.3.1. Dosimetric effects 
4.3.1.1. The base plate 
Figure 4.2 (a) shows the measured beam attenuation by the couchtop and 
baseplate combination as a function of gantry angle. Overall, attenuation 
increases by an approximate factor 1.6 when mounting the baseplate on the 
iBeam evo couchtop. The total attenuation reaches a maximum (7.57±0.39% 
for 6MV and 5.33±0.10% for 15MV) for beams obliquely traversing the 
couchtop and baseplate edge (gantry angle 130° and 120° respectively) and 
steadily decreases for more posterior beams (4.64 ± 0.02% and 3.31 ± 0.03% 
for 6 and 15MV at 180°). This angular dependence reflects the changing 
radiological path through the couchtop and baseplate. Attenuation values also 
rise with decreasing beam energy. 
Additionally, an important loss of build-up is detected for beams 
traversing the couchtop and baseplate combination (figure 4.3). For beams 
traversing the couchtop, the absorbed dose at 1 mm depth varies between 
98.32% to 187.69 % of the dose at 10 cm depth (table 4.1). Mounting the 
baseplate on the couchtop further increases these build-up doses (at 1 mm) by 
8.02% on average. 
4.3.1.3. The support cushion foam 
For the uncoated cushion foam samples, beam attenuation remains limited to 
0.11% (6MV) and 0.08% (15MV) per centimeter thickness. A small and 
statistically insignificant increase in beam attenuation is detected for the 
coated foam samples.  
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Build-up doses, however, increase substantially when irradiating through a 
10 cm thick support cushion (figure 4.4). At 0.0075 mm depth, the absorbed 
dose in a 10x10 cm² field equals 18.73% and 14.59% for the open beam 
versus to 91.19 and 61.81% (6 and 15MV, respectively) for the beam 
traversing 10 cm of foam. At depths beyond 1 mm, excellent agreement 
between film and extrapolation chamber measurements is observed. Similar 
trends are observed for the other fields (figure 4.5 and table 4.1).  
4.3.1.3. The support wedge 
The support wedge is found to attenuate the beam passing through the wedge, 
resulting in a substantial dose decrease (12.28% and 9.37% on average for the 
6 and 15MV beam respectively) behind the support wedge (figure 4.6 (b-d-
e)). Additionally, build-up doses increase by 4.82% and 4.46% (6 and 15MV) 
on average in the contact zone between the wedge and phantom (up to 15 and 
28 mm depth for 6 and 15MV beam respectively). This effect tends to 
increase with decreasing depth: build-up dose increases of up to 53.34% for 
6MV and 87.71% for 15MV are detected towards the surface.  
4.3.2. Modeling in the treatment planning system 
4.3.2.1. The base plate  
Figure 4.2 (b) compares the measured and calculated attenuation for the 
couchtop and baseplate combination as a function of gantry angle. For all 
gantry angles, the measured and calculated attenuation values agree within 
1.01% and 0.75% for 6 and 15 MV beams respectively (mean difference 
0.49% and 0.47%). As the differences between measured and calculated data 
show a similar trend as a function of gantry angle for both energies, we 
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hypothesize these small differences to originate from inaccuracies in the 
REDs obtained from the planning CT. 
In the build-up region, TPS results do show a build-up dose increase when 
mounting the baseplate on the couchtop (figure 4.3). However, the effect of 
both the couchtop and the couchtop-baseplate combination on the build-up 
dose is slightly overestimated for 15MV beams (up to 10% at 1 mm depth) 
and underestimated for 6MV beams (up to 7.21% at 1 mm depth).  
 
 
Table 4.1: Absorbed dose at 1 mm depth as measured by radiochromic film dosimetry 
for open beams and beam traversing 10 cm of support cushion foam, the iBeam evo 
couchtop and the couchtop-baseplate combination. All doses are normalized to the 
absorbed dose at 10 cm depth for the corresponding reference field (i.e. the open 
beam and the beam traversing the couchtop). The uncertainty measures between 
brackets represent the standard error of the mean (?/√n) for three repeated 
measurements.  
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Figure 4.2: Attenuation by the iBeam evo couchtop whether or not in combination 
with the baseplate as a function of gantry angle for 6 and 15 MV beams (10x10 cm²) 
as measured by ionization chamber dosimetry (a) and as calculated by the Monaco 
treatment planning system for the combination (b). The measured data in subplot (b) 
are identical to the data represented in subplot (a). The error bars reflect the standard 
error of the mean (?/√n), based on two repeated measurements or calculations for 
both gantry angles mirrored to the isocentric sagittal plane (for example 100° and 
260°). The lines are drawn only to guide the eye.  
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Figure 4.3: Build-up dose as measured by radiochromic film and as calculated by the 
Monaco treatment planning system for the 10x10 cm² (a), 5x5 cm²(b), 20x20 cm² (c) 
and 10x10 cm² oblique (d) 15MV beams that traversed the couchtop only or the 
couchtop-baseplate combination. In subplot (a-c), the gantry angle equaled 180° 
(perpendicularly incident beams). In subplot (d), the gantry angle equaled 210° 
(obliquely incident beam). These PDDs 23 are normalized to the absorbed dose at 10 
cm depth for the corresponding beam that traverses only the couchtop. The error bars 
reflect the standard error of the mean (?/√n) for the radiochromic film measurements. 
  
                                                     
23 PDD: percentage depth-dose 
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Figure 4.4: Absorbed dose in the build-up region as measured by radiochromic film 
and extrapolation chamber for the 10x10 cm² 6MV (a) and 15MV (b) beams with or 
without a 10cm thick support foam cushion in the beam line (in contact with the 
phantom). PDDs are normalized to the absorbed dose at 10 cm depth in the 
corresponding open beam. The error bars reflect the standard error of the mean (?/√n) 
for the radiochromic film measurements. Extrapolation chamber error bars are 
smaller than the marker size.  
4.3.2.2. The support cushion foam 
For the support cushion foam, the best match between measured and 
calculated attenuation values is obtained with an RED equaling 0.05 24. In this 
case, the calculated attenuation amounts to 0.12% (measured 0.11%) for 6MV 
versus 0.05% (measured 0.08%) for 15MV. This density results in an 
underestimation of the build-up dose when irradiating through a 10 cm foam 
cushion (figure 4.5), by 0.84% to 14.48% and 5.25% to 25.28% at 1 mm depth 
for 6 and 15MV beams respectively. Note, in this respect, that we could not 
24 For the support cushion foam, using the REDs obtained from the CT-to-RED 
conversion table did not affect the calculations for beams traversing 10 cm of foam. 
Therefore, artificial electron densities were manually assigned to the support cushions 
and were optimized to match the calculated attenuation values to the measured ones. 
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assign higher densities to the thin cushion coating layer, which might explain 
the observed build-up dose underestimation. 
 
 
Figure 4.5: Build-up dose as measured by radiochromic film dosimetry and as 
calculated by the Monaco treatment planning system for the 10x10 cm² (a), 5x5 cm² 
(b), 20x20 cm² (c) and 10x10 cm² oblique (d) 15MV beams with or without 10 cm 
support cushion foam in contact with the phantom. These PDDs are normalized to 
the absorbed dose at 10 cm depth for the corresponding beam without foam. The error 
bars reflect the standard error of the mean (?/√n) for the radiochromic film 
measurements.  
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4.3.2.3. The support wedge 
Similarly, TPS calculations accurately predict the attenuation by the support 
wedge as measured in the polystyrene phantom (representing the irradiated 
breast), but overestimate the absorbed dose in the build-up region irrespective 
of the presence of the support wedge (figure 4.6 (e)). In the region behind the 
support wedge, the mean dose discrepancy (calculated versus measured) is 
1.34% and 2.07% (6 and 15MV) for the open beams versus 1.91% and 1.71% 
(6 and 15MV) for beams traversing the support wedge. In the build-up region, 
the absorbed dose (up to 15 and 28 mm depth for 6 and 15MV) is 
overestimated by 6.36% and 5.25% (6 and 15MV) for open beams versus 
6.87% and 7.12% (6 and 15MV) on average for beams traversing the support 
wedge. 
 
4.4. Discussion 
Patient positioning devices have become important tools to guarantee 
accurate delivery of highly conformal dose distributions (Olch et al., 2014; 
Kovacs et al., 2007; Leitzen et al., 2014). In this respect, this study focused 
on the dosimetric impact of the AIO positioning device. 
 
Firstly, our dosimetric study indicated that irradiating through the AIO 
components can cause considerable and clinically relevant dose perturbations 
25. 
                                                     
25 During prone whole breast irradiation at Ghent University Hospital, irradiating 
through the AIO components can mostly be avoided, except for medial tumors for 
which beams may intersect the support wedge for the contralateral breast. For these 
patients, radiation skin reactions have been frequently observed. Whole breast 
irradiation with simultaneous irradiation of the lymph nodes would even require 
beams traversing the AIO components for all patients. 
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Figure 4.6: Absorbed dose for the 15MV beams in the polystyrene phantom 
(representing the irradiated breast) as measured by radiochromic film (a-b) and as 
calculated by the Monaco treatment planning system (c-d) with (b-d) and without (a-
c) the support wedge in the beam line. The measured dose distributions (a-b) show 
excisions for the phantom fixation screws. The calculated dose distribution with the 
support wedge in the beam line also shows the calculated dose distribution in the 
support wedge. Subplot (e) presents the measured and calculated PDDs (average of a 
2.5 mm wide region) along the line depicted in subplots (a-d). PDDs are normalized 
to the absorbed dose in the isocenter as indicated in figure 4.3 (a). 
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In particular, posterior beams traversing the couchtop-baseplate combination 
or beams intersecting large sections of the support wedge for the contralateral 
breast are attenuated substantially.  
Additionally, build-up doses increased considerably when irradiating 
through any of the investigated components, especially the support wedge for 
the contralateral breast. This loss of build-up was the most pronounced for the 
posterior beams traversing the couchtop and the couchtop-baseplate 
combination. In this respect, it is well-known that the carbon fiber sandwich 
design (used in the iBeam evo couchtop and the baseplate), generally results 
in higher build-up doses and more beam attenuation than the older tennis 
racket couchtop designs (Poppe et al., 2007; Seppala and Kulmala, 2011; 
Olch et al., 2014). The double carbon fiber sandwich structure in the 
couchtop-baseplate combination obviously amplifies these effects. 
 
In literature, multiple approaches to incorporate external devices into the 
treatment planning calculations have been proposed (Mihaylov et al., 2008; 
Gerig et al., 2010; Smith et al., 2010). A first approach is to manually edit the 
patients treatment planning CT by adding the device's CT-data 26  or a 
contoured geometric model. A second and faster approach is to directly 
include the device when acquiring the treatment planning CT.  
While this second approach was adopted for inclusion of the AIO 
components, it is not suitable for the inclusion of the linac couchtop, which is 
normally not mounted on the CT scanner. In the Monaco TPS, however, a 
contoured geometric model of the treatment couchtop can be stored and 
incorporated into any imported patient CT. In our study, this approach 
                                                     
26 To date, many software releases do not yet support the replacement of the CT-
couch in the planning CT by a CT-scan of the treatment couch. The TomoTherapy 
planning system (Accuracy, Sunnyvale, CA), however, supported this approach from 
its earliest version (Langen et al., 2010; Olch et al., 2014). 
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allowed to adequately model the couchtop's beam attenuation, but failed to 
accurately predict the absorbed dose in the build-up region. Note, 
additionally, that this method implicitly assumes the patient to be centered 
laterally with respect to the couchtop, as the couchtop model is automatically 
imported into this position. Manual correction is possible, but then requires 
an accurate and reproducible positioning of the patient on the couchtop.  
 
For the AIO positioning device, in contrast, all components were included 
during CT scanning. As the AIO solution is an indexed patient immobilization 
device, this approach ensures an accurate representation of the patients' set-
up geometry as well as excellent inter-fraction set-up reproducibility. Using 
the CT data, the Monaco treatment planning system accurately calculated 
beam attenuation by both the AIO baseplate and the support wedge for the 
contralateral breast. Modeling the beam attenuation by the support cushion 
foam required a manual density overwrite of all traversed support cushions 
(RED 0.05).  
Regarding build-up doses, less accurate results were obtained. Even 
though the Monaco treatment planning system did predict build-up dose 
increases when irradiating through the AIO components, considerable 
discrepancies between measurements and calculations persisted 27 . These 
                                                     
27  Besides the accuracy of the positioning device’s RED used during treatment 
planning, these discrepancies might also relate to other factors generally affecting 
build-up dose calculation accuracy. These factors are discussed in Section 6.3 and 
include, for example, the use of rather simple models for electron contamination and 
the quality of the measurement data provided for beam modelling. As a consequence, 
build-up calculation accuracy in beams traversing patient positioning devices could 
be improved by optimizing the CT-to-RED conversion for low- and high-density 
materials, as well as by measures optimizing build-up calculation accuracy in general. 
These might include the development of more complex models for electron 
contamination, the introduction of more accurate build-up dose measurements for 
beam modelling and the refinement of the calculation grid sizes in the build-up 
regions (see Section 6.3). 
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discrepancies were the most pronounced for the 10 cm support cushion foam 
for which an artificial RED was assigned and optimized to match beam 
attenuation measurements, clearly illustrating that the approach followed 
does not adequately account for the attenuation and generation of particles 
within the cushion foam and coating. For beams that traverse the support 
wedge, a large air gap is intersected before reaching the patient surface. In 
this respect, Gray et al. (2009) investigated the build-up calculation accuracy 
of the anisotropic analytical algorithm implemented in the Eclipse TPS 
(Varian Medical Systems, Palo Alto, CA) for beams traversing solid water 
slabs and a large air gap before reaching the patient. Similar to our results 
observed for the carbon-fiber support wedge and the Monaco TPS, the AAA 
calculations were found to overestimate the build-up doses by up to 5.5%. 
One additional critical factor in our approach is the accuracy of the 
device's RED obtained from the planning CT data. As most CT-to-RED tables 
are not optimal for the very low- or high-density materials used within 
external devices, one must always carefully analyze the obtained REDs and 
associated dosimetric results (Schneider et al., 1996; Skrzynski et al., 2010; 
Zurl et al., 2014). Additionally, including the complete positioning device 
into the treatment planning CT generally requires the use of a larger field-of-
view. The use of such extended fields-of-view might affect the accuracy of 
the CT Hounsfield numbers and requires careful analysis of the obtained data 
(Smith et al., 2010).  
4.5. Conclusion 
Irradiating through the components of the AIO patient positioning device can 
cause considerable and clinically relevant dose perturbations. Posterior beams 
traversing the couchtop-baseplate combination or beams intersecting large 
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sections of the support wedge for the contralateral breast are substantially 
attenuated. Build-up doses increased considerably when irradiating through 
all investigated components. The inclusion of the AIO components in the 
treatment planning CT allowed to accurately model the most important 
attenuation effects, but failed to precisely predict build-up doses. 
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Abstract 
Purpose. To report the dosimetric results and impact of volumetric arc 
therapy (VMAT) on temporary alopecia and hair-loss related quality of life 
(QOL) in whole brain radiotherapy (WBRT).  
Methods. The potential of VMAT-WBRT to reduce the dose to the hair 
follicles was assessed. A human cadaver was treated with both VMAT-
WBRT and conventional opposed field (OF) WBRT, while the 
subcutaneously absorbed dose was measured by radiochromic films and 
calculated by the planning system. The impact of these dose reductions on 
temporary alopecia was examined in a prospective phase II trial, with the 
mean score of hair loss at 1 month after VMAT-WBRT (EORTC-QOL 
BN20) as a primary endpoint and delivering a dose of 20 Gy in 5 fractions. 
An interim analysis was planned after including 10 patients to rule out futility, 
defined as a mean score of hair loss exceeding 56.7. A secondary endpoint 
was the global alopecia areata severity score measured with the “Severity of 
Alopecia Tool” (SALT) with a scale of 0 (no hair loss) to 100 (complete 
alopecia).  
Results. For VMAT-WBRT, the cadaver measurements demonstrated a dose 
reduction to the hair follicle volume of 20.5% on average and of 41.8% on 
the frontal-vertex-occipital medial axis as compared to OF-WBRT. In the 
phase II trial, a total of 10 patients were included before the trial was halted 
due to futility. The EORTC BN20 hair loss score following WBRT was 95 
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(SD 12.6). The average median dose to the hair follicle volume was 12.6 Gy 
(SD 0.9), corresponding to a 37% dose reduction compared to the prescribed 
dose. This resulted in a mean SALT-score of 75.  
Conclusions. Compared to OF-WBRT, VMAT-WBRT substantially 
reduces hair follicle dose. These dose reductions could not be related to an 
improved QOL or SALT score.  
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5.1. Introduction 
Whole brain radiotherapy (WBRT) increases survival in patients with brain 
metastases (Ruderman and Hall, 1965; Gaspar et al., 1997; Horton et al., 
1971), but has also been shown to reduce Quality of Life (QOL) by increasing 
drowsiness, leg weakness and hair loss (Steinmann et al., 2009). Hair loss is 
typically observed in all patients undergoing WBRT (Gerrard et al., 2003) 
and was reported as one of the main factors reducing QOL scores when 
WBRT is used in the prophylactic setting in small cell lung cancer (Slotman 
et al., 2009). 
The standard WBRT technique applies 2 lateral opposed fields (OF-
WBRT) with a margin around the brain including the hair follicles, which are 
located approximately 5 mm below the scalp (de Viragh and Meuli, 1995). 
Irradiation-induced epilation is due to high susceptibility of anagen follicles 
to radiation (Wen et al., 2003). Complete hair regrowth generally occurs 2-4 
months after irradiation (Wen et al., 2003), which often exceeds the life 
expectancy in poor prognostic patients. Therefore, significant gains in QOL 
might be obtained by developing a hair sparing WBRT technique. Recent 
technological improvements in patient positioning and radiotherapy treatment 
planning may allow us to treat the whole brain with reduced margins, 
allowing better sparing of the scalp (Ting et al., 2005; Mancini et al., 2010; 
Roberge et al., 2005). Furthermore, the use of arc techniques may minimize 
the follicle dose, as the reduction of surface dose is then distributed over the 
length of the arc (Lawenda et al., 2004). 
The purpose of this study was to investigate the impact of VMAT-WBRT 
on temporary alopecia and hair loss related QOL. The dose-effect relation of 
temporary alopecia is, however, poorly investigated and, to our knowledge, 
the available data remain limited to permanent alopecia (Lawenda et al., 
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2004; Severs et al., 2008). Furthermore, plan optimization and evaluation for 
the hair follicle volume is impeded by the known inaccuracies of the treatment 
planning system in calculating build-up doses (Hsu et al., 2010). In order to 
overcome these issues, our study combines a dosimetric study and a 
prospective phase II trial for the treatment of patients with brain metastases, 
relating the measured and computed dose reductions to temporary alopecia 
and hair loss-related QOL. 
5.2. Materials and Methods 
5.2.1. Dosimetric evaluation 
In order to quantify the potential of VMAT-WBRT to reduce the dose to the 
hair follicles and to evaluate the treatment planning system's accuracy in 
predicting these values, a human Thiel-embalmed cadaver (Thiel, 1992) 
implanted with 13 radiochromic films in the scalp was treated with both OF- 
and VMAT-WBRT (local Institutional Review Board reference EC UZG  
2012/401). 
5.2.1.1. Treatment techniques 
The OF-WBRT plan consisted of two lateral opposed beams, with the gantry 
at 90° and 270° with the field borders set at 2 cm beyond the bony skeleton 
in the superior, anterior and posterior direction. The collimator was rotated to 
allow the inferior border to parallel the base of skull. The inferior border was 
set from the bony canthus to the C1-2 interverebral space, covering the base 
of the skull with a 1-cm margin. The VMAT-WBRT plan used a single arc of 
352° (from -176° to +176°) without gaps in delivery. Both techniques 
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employed 6 MV photons from a linear accelerator equipped with an MLCi2 
multileaf collimator (Elekta Synergy, Elekta, Crawley, UK). The clinical 
target volume was the whole brain (to the inner table of the skull and 1 cm 
inferior for the foramen magnum), delineated on a contrast enhanced 
computed tomography (CT, 1mm slices, Toshiba Aquilion LB scanner, 
Toshiba Medical Systems, Tokyo, Japan) and expanded with 2 mm in all 
directions creating a planning target volume (PTV) for both techniques. The 
hair follicle volume was defined as the tissue underlying the skin up to the 
outer table of the skull. An automated script was written in Pinnacle, version 
9.0 (Philips Medical Systems, Andover, MA, US), to automatically contour 
this volume with the creation of 4 subvolumes representing the different areas 
of the scalp (figure 5.1): top (vertex), back (posterior aspect of the scalp), left 
(left profile of the scalp) and right (right profile of the scalp) (Olsen et al., 
2004). A median dose of 20 Gy (5 fractions) was prescribed to the PTV 
according the ICRU recommendations (95% - 107%) (Bethesda, 1999) while 
the dose to the hair follicle volume was reduced maximally without 
compromising the dose to the brain. Optimization and dose calculation were 
first performed using the VMAT-extended GRaTiS program (Sherouse, 
1989; Ost et al., 2011) with final dose calculations in Pinnacle. 
During treatment, the cadaver was positioned on a personalized head 
support and immobilized with a thermoplastic mask (Marcomedics, 
Waddinxveen, The Netherlands). The positioning of the brain was corrected 
using cone beam CT, with co-registration based on the bony anatomy 
(Guckenberger et al., 2007). 
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Figure 5.1: The hair follicle volume was defined as the tissue underlying the skin up 
to the outer table of the skull. An automated script was written in Pinnacle, version 
9.0 (Philips Medical Systems, Andover, MA, US), to automatically contour this 
volume with the creation of 4 subvolumes representing the different areas of the 
scalp: top (vertex, pink), back (posterior aspect of the scalp, orange), left (left profile 
of the scalp, blue) and right (right profile of the scalp, red). Panel A: frontal view, 
panel B, lateral view, panel C: cranial view. 
 
5.2.1.2. Radiochromic film dosimetry 
Thirteen radiochromic films (2.2 x 2.2 cm², EBT2 lot nr. A06271203, 
Gafchromic, Ashland Specialty Ingredients, Wayne, NJ, USA) were 
implanted equally distributed across the cadaver scalp (figure 5.2). They were 
protected from the cadaver's embalmment fluid by wrapping them in a plastic 
paraffin film casing (Parafilm, Pechiney Plastic Packaging Company, 
Chicago, Illinois). As the internal structure of the cadaver skin cannot be 
discerned macroscopically, all films were implanted subcutaneously 28 . 
Consequently, their implantation depth always exceeded the hair follicle 
depth. Moreover, all films were positioned within the build-up region with 
doses generally rising with depth. Therefore, we assume their measured doses 
to serve as an estimation and upper limit for the dose to the hair follicles. The 
                                                     
28 An incision in the cadaver skull allowed to lift a skin section without removing it 
from the remainder of the skin. The film was subsequently positioned subcutaneously 
underneath this skin section. The skin was repositioned and over the films and sutured 
to secure the film and skin position. 
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implantation depth was estimated using CT images and ranged from 2.0 to 
11.7 mm. 
Radiochromic films were digitized on an Epson Expression 10000XL 
flatbed scanner (Seiko Epson Corporation, Suwa, Nagano, Japan) and 
analyzed using the net optical density (OD) in the red color channel 29 (De 
Puysseleyr et al., 2012). The mean doses and dose-volume-histograms were 
computed for the complete films, only excluding a narrow strip along the 
film's edge and the small orientation markers on the film. All reported relative 
doses and dose differences are normalized to both plans' prescription dose 
(per fraction) of 4 Gy. 
 
 
Figure 5.2: Distribution of the film measurement locations across the scalp. 
 
The films were not present in the cadaver during planning CT imaging. 
Instead, the visibility of their positions was enhanced by replacing them with 
2.2x2.2x0.02 cm3 aluminum plates 30 . We observed no impaired image 
                                                     
29 The sensitometric curves for the radiochromic films were determined using a 
Farmer ionization chamber (type 30012, PTW Freiburg, Freiburg). The traceability 
to a primary standard was ensured by calibration of this chamber in a standard 
laboratory. 
30 The aluminum plates were implanted subcutaneously using the same procedure as 
for the radiochromic films. As the area of the incision was only marginally larger than 
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distortion for the applied CT settings. The films were exposed to the kV-
irradiation of the CBCT cadaver during positioning procedures. The impact 
of these procedures on the films’ OD was assessed by exposing one set of 
films to the CBCT irradiation only. As the CBCT induced film response 
corresponded to only 0.56% of the prescription dose on average, the CBCT-
related film darkening was neglected in further experiments.  
5.2.1.3. Dose calculation accuracy 
The dose calculation accuracy of the collapsed-cone convolution (CCC) 
algorithm implemented in Pinnacle was evaluated by comparing the 
measured and calculated data. To that purpose, the outline of the aluminum 
plates in the CT images served for contouring the location of the radiochromic 
films. The density within these contours was overridden with the density of 
the surrounding dermal tissue (1.07 g/cm³). As the calculation grid is 
generally considered a determinative parameter for dose calculation accuracy 
in the build-up region (Hsu et al., 2010), the calculations were performed for 
both the clinically used 4 mm, as well as for a 1 mm calculation grid. Within 
these computations, the fluence density grid always equaled the calculation 
grid. The mean absorbed doses and dose-volume-histograms were then 
computed for all radiochromic film positions. 
the area of the aluminum plates and radiochromic films, this procedure allowed for 
accurate positioning of the aluminum plates with respect to the film positions. 
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5.2.2. Phase II trial 
5.2.2.1. Patients and procedures 
Eligible patients who presented at the department of radiation oncology of 
Ghent University Hospital were recruited for the study. Eligibility 
requirements were: age ≥18, brain metastases eligible for WBRT: recursive 
partitioning analysis (RPA) class I or II and > 3 brain metastases or RPA class 
III or meningitis carcinomatosa, and signed written informed consent. 
Patients were excluded if they received prior cranial radiotherapy, had pre-
existing alopecia or were diagnosed with leukaemia, lymphoma or germ-cell 
tumour. The study was approved by the local Institutional Review Board 
(reference number: EC2011/504) and registered at clinicaltrials.gov: 
NCT01421316. 
All patients received VMAT-WBRT for brain metastases detected with 
brain contrast-enhanced computed tomography and/or magnetic resonance 
imaging within 1 month before enrolment. The delineation, treatment 
planning and delivery for the VMAT technique has been described above.  
The primary endpoint was the mean score of hair loss at 1 month after 
VMAT-WBRT scored with the European Organization for Research and 
Treatment of Cancer (EORTC) Quality of Life Questionnaire Brain Cancer 
Module (EORTC-QLQ-BN20) (Osoba et al., 1996). The EORTC-QLQ-
BN20 is designed for use with patients undergoing chemotherapy or 
radiotherapy, and is composed of 20 questions assessing visual disorders, 
motor dysfunction, communication deficit, various disease symptoms (e.g., 
headaches and seizures), treatment toxicities (e.g., hair loss), and future 
uncertainty. This questionnaire was used as a supplement to the EORTC-
QLQ-C15-PAL (Groenvold et al., 2006). The questions on both measures 
were scaled, scored and reported using the recommended EORTC procedures 
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(Aaronson et al., 1993) (Bottomley et al., 2005). As a secondary endpoint, 
the global alopecia areata severity score was used (combination of extent and 
density of scalp hair loss) (Olsen et al., 2004). The total score is calculated by 
visually determining the amount of terminal hair loss in each of the four views 
of the scalp and adding these together with a maximum score of 100% 
corresponding with complete alopecia. This global severity score may be 
called the ‘‘Severity of Alopecia Tool’’ or SALT score. The four views of the 
scalp were photographed in standardized conditions before radiotherapy and 
1 month after radiotherapy (Olsen et al., 2004).  
 
5.2.2.2. Sample size and statistical analysis 
At 1 month following OF-WBRT, the mean score of hair loss (EORTC BN20) 
is 36.7 (out of 100, with a standard deviation of 17) compared to 11.7 in an 
untreated patient group (Slotman et al., 2009). We hypothesize that with 
VMAT-WBRT, the mean score of hair loss will be 15 points lower compared 
to OF-WBRT. (Bottomley et al., 2005). Differences of at least 10 points (on 
a 0 to 100 scale) are classified as the minimum clinically meaningful change 
in the mean value of a HRQOL parameter. Mean changes of more than 20 
points were classed as large effects. To detect a significant result at the 5% 
level, with 80% power we would need to treat 21 patients in this single arm 
study. With an estimated dropout of 20%, due to the median prognosis of 2 
months, we aimed to include 26 patients. Descriptive statistics were used to 
calculate means and standard deviations. The QOL and SALT score results 
are presented as mean scores and were compared between time points using 
the Wilcoxon signed rank test (p < 0.05 considered significant). An interim 
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analysis was planned after including 10 patients to rule out futility, defined as 
a mean score of hair loss exceeding 56.7. 
 
5.3. Results 
5.3.1. Dosimetric evaluation 
The cadaver's planning results are depicted in figure 5.3, demonstrating the 
DVH's calculated with a 1 mm dose grid, and table 5.1, showing the 
corresponding calculated median doses. Compared to the OF-plan, the 
VMAT computations clearly predict a mean dose decrease of approximately 
25% in the total hair follicle volume. The highest reductions are found in the 
hair top and back subvolumes, where a high-dose region in the OF-plan is 
transformed into a low dose region for the VMAT-plan.  
 
 VMAT-WBRT (%) OF-WBRT (%) 
hair follicle  
subvolume 
calculated D50 calculated D50 calculated D50 calculated D50 
1mm grid 4mm grid 1mm grid 4mm grid 
left 81.4 78.4 97.58 92.92 
right 80 75.9 93.99 89.82 
back 62.3 59.8 103.40 94.09 
top 67.3 60.8 106.60 90.79 
total 72.4 68.5 100.10 92.34 
 
Table 5.1: Calculated median doses (D50) for the hair follicle volume and its 
subvolumes for the VMAT- and OF- plan normalized to the prescription dose per 
fraction (4 Gy). 
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Figure 5.3: DVH's for the VMAT- and OF- WBRT cadaver plans calculated with a 
1 mm dose grid for 1 fraction (prescription dose 4 Gy). 
As illustrated in table 5.2, our radiochromic film measurements conclusively 
confirmed these predicted tendencies. For all films in the VMAT-plan, an 
important dose reduction was found compared to the OF-plan, with an 
average film dose reduction of 20.5%. As predicted by the TPS, the OF-plan 
demonstrated a remarkable high-dose region on the hair top and back 
subvolumes (mean dose 112.2% for films 8, 11-13), which is transformed into 
a low dose region in the VMAT-plan (mean dose 70.4%).  
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Table 5.2: Mean measured and calculated doses for all films implanted 
subcutaneously in the cadaver, normalized to the prescription dose per fraction (4 
Gy). The corresponding standard deviations, representing dose variations within each 
film, amounted to approximately 3.5% and 1.9% for the VMAT- and OF- films 
respectively. As the dose-volume-histograms for all detectors equally showed little 
dose variation within each film, further data analysis was uniquely based on the mean 
dose per film. 
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The calculation accuracy of the mean dose of the film was found to be similar 
for both techniques, except for the films on the frontal-vertex-occipital medial 
axis. For the clinically used 4 mm calculation grid, the mean dose discrepancy 
between measurements and calculations equaled 6.9% and 6.4% for the OF- 
and VMAT-plan respectively. In the OF-plan, however, the use of this 4 mm 
grid resulted in remarkable accuracy degradation on the frontal-vertex-
occipital medial axis. The high dose in this region was then underestimated 
by 16.22% on average and 22.9% at maximum. In the corresponding lower 
dose region in the VMAT-plan, this tendency was much less pronounced, 
demonstrating a mean dose discrepancy of 8.2% only. The use of a 1 mm 
calculation grid size resolved this issue. The average dose discrepancy then 
amounted to 4.3% and 4.1% for the VMAT- and OF- plan respectively with 
a maximum discrepancy of 3.2% on the frontal-vertex-occipital medial axis. 
 
5.3.2. Phase II trial  
A total of 10 patients were included between 26/10/11 and 25/05/2012 before 
the trial was halted due to futility at time of the interim analysis. We treated 
6 male and 4 female patients; with a median age of 63 years (range 45-72). 
The primary tumour site was lung (n=5), pancreas (n=2), breast, prostate and 
colon. All patients were RPA class I (n=5) or II (n=5). The median number 
of metastases treated was 4 (range: 1-7). 
As illustrated in table 5.3, the average median dose to the hair follicle 
volume was 12.6 Gy (SD 0.9), which corresponds to a 37% dose reduction 
compared to the prescribed dose of 20 Gy. For the 4 subvolumes of the hair 
follicle volume, the dose was reduced with 22%, 20%, 44% and 48% for the 
left side, right side, top of head and back of head, respectively. For all hair 
follicle subvolumes, the mean doses predicted by the TPS for the patient 
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group differed by only 7.3% at maximum from the corresponding doses 
calculated for the cadaver. 
 
Two patients died before reaching 1 month follow-up. For the remaining 8 
patients, the mean score of hair loss, as measured with the EORTC BN20 
questionnaire prior to WBRT, was 9.5 (SD 16.2) compared to 95 (SD 12.6) 
after WBRT (p = 0.01). The mean total SALT score before WBRT was 0 (SD 
0) compared to 75 (SD 13) after WBRT, corresponding to 75% hair loss. One 
patient was excluded from the photographic scoring after shaving his head. 
When sub-stratifying the score according to the four subvolumes, we 
observed a mean hair loss of 96%, 96%, 65% and 60% at the left side, right 
side, top of scalp and back of scalp, respectively (p = 0.04). A lateral view of 
a patient with 55% hair loss according to the SALT- score is depicted in figure 
5.4. 
 
Table 5.3: Patient planning results of the phase II trial for the different hair follicle 
subvolumes for 5 fractions (prescription dose 20 Gy). 
 
5.4. Discussion  
In literature, the interpretation of data on intensity modulated techniques in 
hair-sparing WBRT (Roberge et al., 2005; Mancini et al., 2010) has been 
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impeded by the lack of knowledge on the dose-effect relation of temporary 
alopecia. Additionally, plan optimization and evaluation in the hair follicle 
region is limited by known inaccuracies of the TPS in calculating build-up 
doses (Hsu et al., 2010). As a consequence, the available dosimetric studies 
by Roberge et al. (2005) and Mancini et al. (2010) do not allow to predict 
these techniques' impact on temporary alopecia. This investigation is, to our 
knowledge, the first study to overcome these issues by quantitatively relating 
dose measurements and planning data to clinical results on temporary 
alopecia in WBRT 31. 
In this respect, our dose measurements demonstrated the potential of VMAT-
WBRT to reduce the subcutaneously absorbed dose by 20.5%. Roberge et al. 
(2005), for comparison, measured a dose reduction of 53% at 1 mm depth 
with TLD's and calculated a dose reduction of 38% within the first 5 mm of 
the skin when comparing IMRT to OF-WBRT. Note, however, that our study 
reports the subcutaneously absorbed dose, serving as an upper limit for hair 
follicle dose, rather than the dose measured at the surface by Roberge et al. 
(2005). 
Consequently, as the sparing of any organ at risk depends on its distance to 
the target volume, the sparing of the more superficially positioned hair 
follicles will most likely exceed rather than be smaller than our reported 
values. Interestingly, the lowest doses in VMAT-WBRT were found on the 
top of the scalp, where high doses typically occur in OF-WBRT. These high 
OF-doses might be attributed to the extremely oblique and overlapping 
incidence of opposed beams, thus boosting surface dose and degrading the 
31 Even though this investigation is the first study to combine both dosimetric and 
clinical results on temporary alopecia in hair-sparing WBRT, the study design does 
not allow to correlate the measured nor calculated doses to the presence or degree of 
temporary alopecia. 
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modelling accuracy of the TPS. The use of arc techniques obviously mitigates 
this effect by spreading it out across the scalp. Combined with the 
concomitant lack of exit dose in this region compared to the remainder of the 
scalp, this effect results in a low dose region in the VMAT-plan. A more 
optimized OF-WBRT could probably improve the doses to the hair follicle 
region, when using portals shaped around the PTV, the use of compensation 
and higher energy photons. 
 
 
Figure 5.4: Lateral view of a patient's scalp with a 55% hair loss according to the 
SALT-score, but scoring 100 on the EORTC hair loss scale. 
 
Most importantly, our phase II trial provided valuable insight into the impact 
of these dose reductions on the risk of temporary alopecia. As for the human 
cadaver, the patients’ doses in the hair follicle left and hair right subvolumes 
were predicted to be around 15-17 Gy for 5 fractions respectively and were 
related to 96% hair loss. However, as for the cadaver, the TPS equally 
predicted a low dose region of 10.5-11.3 Gy on the frontal-vertex-occipital 
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medial axis (top and back subvolumes), resulting in 60 to 65% hair loss. 
Based on these data, we hypothesize that the threshold TPS dose for 
temporary alopecia is around or slightly lower than 10 Gy in 5 fractions, as 
some but not all of the patients retained their hair in this region. In contrast, 
in the abstract of Ting et al. (2005) a mean calculated scalp dose of 18.5 Gy 
(within the first 3 mm of tissue underlying the skin) delivered in 10-15 
fractions in IMRT-WBRT was related to subjectively reduced hair loss in all 
patients. Half of the patients demonstrated no noticeable hair loss, while the 
other half experienced subjectively mild hair loss. However, they neither 
quantitatively scored hair-loss nor assessed QOL, making it difficult to 
compare results.  
Although some patients retained their hair on the top and back of the head, 
this was not related to an improved QOL. Following a pre-planned interim 
analysis, the rules for futility were met, with a mean score of hair loss 
exceeding 56.7 on the EORTC BN20 (mean score of 95). The score of hair 
loss in our study was higher than in the literature, where in general scores 
between 30 and 40 are reported (Slotman et al., 2009; Steinmann et al., 2009; 
Steinmann et al., 2012; Caissie et al., 2012). In the study of Steinman et al. 
and Slotman et al., 42% and 22% of patients showed an increase in hair loss 
scores exceeding 20 points, respectively, compared to all patients in our 
study. In a recent study of VMAT-WBRT with simultaneous integrated boost 
for brain metastases, the mean score of hair loss was 23.8 (Weber et al., 2011), 
which is lower compared to literature of OF-WBRT and in range of our 
primary objective to lower the score to 21.7. We hypothesize that the worse 
score in the current study compared to literature is due to the patients’ 
knowledge of the primary goal of VMAT-WBRT to reduce hair loss. This 
discordance is reflected in figure 5.4, showing a lateral view of a patient 
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scoring 100 on the EORTC hair loss scale although hair loss was only 55% 
according to the SALT score. 
Further improvements to reduce alopecia might require the combination 
of a reduced dose to the hair follicles in combination with radioprotectors 
designed to reduce the damage to the normal tissues caused by radiation, such 
as nitroxides, antioxidants (Citrin et al., 2010). As an alternative, the dose to 
the uninvolved brain might be decreased to reduce toxicity. This approach is 
currently tested with hippocampal sparing to avoid memory loss (Gondi et 
al., 2010). However, a dose reduction to the peripheral zone of the brain to 
avoid alopecia should be approached carefully as most brain metastases are 
located in the outer cortex of the brain (Gondi et al., 2010 ). 
5.5. Conclusion 
Compared to OF-WBRT, VMAT-WBRT substantially reduces hair follicle 
dose, especially on the frontal-vertex-occipital medial axis. Our phase II trial 
was halted due to futility with a EORTC BN20 hair loss score of 95 (SD 12.6) 
and a mean SALT score of 75. 
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In megavoltage photon radiotherapy, accurate knowledge of the absorbed 
dose in the build-up region is essential in the clinical management of skin 
toxicity and superficial target coverage. The physical phenomena in the build-
up region, however, complicate both build-up dose measurements and 
calculations. As a result, multiple dosimetric techniques and commercially 
available treatment planning systems fail to accurately determine build-up 
doses. Additionally, as build-up doses vary with a wide range of treatment 
parameters, they were shown to evolve in close relation with innovations in 
treatment technology. In this respect, this dissertation focused on the impact 
of recent evolutions in treatment technology on the absorbed dose and 
calculation accuracy in the build-up region. 
 
6.1. Radiochromic film as a build-up dosimeter 
One of the most fundamental factors limiting build-up knowledge is the 
difficulty to accurately measure build-up doses, arising from the steep dose 
gradient, presence of contaminating radiation and lack of electronic 
equilibrium. In this respect, our studies clearly identified radiochromic film 
in parallel orientation with respect to the beam axis as a reliable build-up 
detector. 
The use of radiochromic film for build-up dosimetry is extensively 
documented in literature, mainly because of its high spatial resolution, low 
spectral sensitivity and near-tissue equivalence (Chiu-Tsao and Chan, 2009; 
Butson et al., 1999; Cheung et al., 2002). Few authors, however, explored the 
use of radiochromic film in parallel orientation with respect to the beam axis 
(Paelinck et al., 2005). For build-up dosimetry, the most important advantage 
of this orientation is the potential to measure the dose in the complete build-
up region, rather than at one specified depth. In our studies, parallel oriented 
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radiochromic film data were compared to extrapolation chamber 
measurements at depths beyond 1 mm (Sections 3.3.1 and 4.3.1.3). At these 
depths, MC simulations have suggested limited SPR variations and 
extrapolation chamber data can be considered a reliable reference (Andreo 
and Brahme, 1986; Abdel-Rahman et al., 2005). Consequently, the excellent 
agreement between the radiochromic film and extrapolation chamber data in 
these experiments clearly identified parallel oriented radiochromic film as a 
reliable relative build-up detector at depths beyond 1 mm. 
An important disadvantage of parallel radiochromic film, on the other 
hand, is the restriction to measurement depths greater than 1 mm. Optical 
densities within the first millimeter from the film edge cannot be analyzed, as 
they might be affected by the mechanical pressure during film cutting by the 
user (Yu et al., 2006) or during manufacturing. Additionally, potential air 
gaps between the film and phantom slabs might result in measurement 
inaccuracies on the central axis. Such inaccuracies should be avoided by a 
meticulous phantom design or by positioning the radiochromic films slightly 
off the central axis (Suchowerska et al., 2001). Possible alternative 
approaches to parallel radiochromic film include the use of extrapolation 
chambers, microdiamond detectors or perpendicularly oriented radiochromic 
film stacks (Chiu-Tsao and Chan, 2009). These detectors, however, are less 
versatile with respect to phantom surface curvature, which is an important 
determinant of build-up dose. 
The accuracy obtained in radiochromic film dosimetry will not only 
depend on the radiochromic film, but also on the digitizer and analysis 
protocol used. For the older HS radiochromic film model, Devic et al. (2004) 
quantified the uncertainty on the experimental OD measurement and on the 
calibration fit procedure for seven different digitizers. Depending on the 
selected scanner, the uncertainty caused by the experimental measurement 
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varied between 1% and 3%, while the calibration fit uncertainty ranged from 
2% to 4% for doses above 5Gy. Note, however, that the total uncertainty will 
not only depend on the digitizer and measurement protocol used, but also on 
the radiochromic film type used. As a results of the higher sensitivity in the 
newer EBT film models, similar levels of uncertainty can be obtained at lower 
dose levels. For the recent EBT3 film type, Sorriaux et al. (2013) extensively 
discuss the uncertainty budget for EBT3 compared to EBT2 radiochromic 
film, when scanned on the Epson Expression 10000XL flatbed scanner. In 
Chapter 2, this flatbed scanner was compared to the Nikon Coolscan 9000 ED 
transmission scanner, which was identified as the preferential tool for high-
gradient dosimetry. One application of high-gradient dosimetry is, for 
example, build-up dosimetry with parallel oriented radiochromic films. 
Compared to the widely used Epson Expression 10000XL scanner, this 
digitizer demonstrated a higher sensitivity, resulting in more contrast in the 
digitized image. The absence of a glass bed for film positioning additionally 
prevents the formation of Newton's rings. This feature comprises a major 
advantage in EBT2-dosimetry, but is less valuable to the more recent EBT3 
films, which have a non-reflective coating and a polyester substrate 
containing silica beads to prevent the formation of interference patterns. The 
silica beads prevent the formation of Newton's rings by ensuring a gap 
between the film and glass surface with a thickness of approximately ten 
times the wavelength of visible light (Borca et al., 2013). 
The main limitation of the Nikon digitizer is its film size restriction to 
6.2x20  cm². It remains, however, the preferential tool for high-gradient 
dosimetry limited to small film sizes. An extensive discussion of this 
scanner's characteristics is provided in Chapter 2. For the Epson Expression 
1680 Pro flatbed scanner, employed in Chapter 3, a summarized discussion 
of the dosimetric uncertainties is provided in Section 3.4. More extensive data 
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on the Epson Expression 10000XL scanner, used in Chapters 4 and 5, is 
provided in Chapter 2. 
 
6.2. The evolution of build-up doses with 
treatment technology 
6.2.1. Flattening filter-free linear accelerators   
Flattening filter-free (FFF) linear accelerators have recently become 
commercially available and currently face swift implementation into clinical 
practice. In clinical practice, FFF fields are especially beneficial to reduce 
beam delivery times in stereotactic radiotherapy and during breath-hold or 
gated beam delivery for organ motion management (Georg et al., 2011). 
Removal of the flattening filter can, however, also be expected to impact 
build-up doses. For the Elekta Precise linear accelerator (Elekta, Crawley, 
UK), in which the flattening filter could be removed and a 2 mm steel disk 
facilitating beam steering could be inserted, our results demonstrate build-up 
doses to be similar to slightly higher for unflattened compared to flattened 
beams (Chapter 3). A similar tendency was observed in both MC simulations 
and measurements on the commercially available Varian Truebeam 
accelerator (Varian Medical Systems, Palo Alto, CA) (Wang et al., 2012; 
Javedan et al., 2014). These results all indicate that, regarding build-up doses, 
the shift of the X-ray spectrum to lower energies in FFF mode is nearly 
compensated by the reduction of electron contamination and head scatter. As 
a consequence, the build-up dose differences between respective FF versus 
FFF fields were very small and might be clinically irrelevant. 
Superficial doses in clinical FFF plans will, however, not only depend on 
the build-up doses in single FFF fields, but also on the treatment parameters 
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used. The use of different parameters (e.g. field size and angle of incidence) 
between FF and FFF mode might additionally affect superficial doses. To our 
knowledge, only Javedan et al. (2014) compared build-up doses in clinical FF 
versus FFF treatment plan pairs. For a head-and-neck and breast case using 
step-and-shoot IMRT, slightly higher build-up doses were found in FFF 
mode. However, as only IMRT plans using the same beam arrangements in 
FF and FFF mode were considered, this investigation does not fully 
encompass all potential differences between the FF and FFF modality. 
 
6.2.2. Patient positioning devices   
The second technical evolution investigated concerns the increasing use of 
patient positioning devices (Olch et al., 2014) to ensure set-up accuracy while 
delivering highly conformal dose distributions. In literature, extensive data is 
available on the dosimetric effects of treatment couch tops, but few authors 
have focused on patient positioning devices (Olch et al., 2014). Therefore, we 
investigated the dosimetric effects when irradiating through the widely used 
AIO patient positioning device (Orfit Industries, Wijnegem, Belgium). In 
contrast to the moderate impact of flattening filter removal, the presence of 
this device in megavoltage photon beams was found to cause considerable 
and clinically relevant build-up dose increases. In clinical practice, the most 
common approach to minimize such effects is to avoid beam incidences 
intersecting such external devices. However, avoiding beams traversing these 
devices is not always possible and modern volumetric arc techniques benefit 
from a wide range of available beam incidences. During prone whole breast 
irradiation at Ghent University Hospital for example, irradiating through the 
AIO components can mostly be avoided, except for medial tumors where 
beams may intersect the support wedge for the contralateral breast. For these 
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patients, radiation skin reactions have been frequently observed. Whole breast 
irradiation with simultaneous irradiation of the lymph nodes would even 
require beams traversing the AIO components for all patients. For these 
treatments, accurate modeling by the treatment planning system (TPS) of the 
dose perturbations is highly recommended. The feasibility of such modeling 
in the Monaco TPS is discussed in Sections 4.4 and 6.3. 
6.2.3. VMAT whole brain radiotherapy  
Finally, we evaluated the potential of modern volumetric arc techniques to 
intentionally reduce the superficial dose to the hair follicles and prevent 
temporary hair loss in whole brain radiotherapy (WBRT). In contrast to the 
standard lateral opposed fields (OF-WBRT), the use of arc techniques allows 
to spread out the superficial doses over the length of the arc. Accordingly, 
radiochromic film measurements demonstrated VMAT-WBRT to reduce the 
subcutaneously absorbed dose by 20.5% on average compared to OF-WBRT. 
The highest reductions (41.8% on average) were found on the top and the 
back of the skull. 
Additionally, as the dose-effect relation of temporary alopecia is still 
poorly understood, a prospective phase II trial was performed to 
quantitatively relate these dose measurements and planning data to clinical 
results on temporary alopecia in WBRT. In accordance with the dose 
measurements, the mean hair loss in the study subjects was the least 
pronounced on the top and the back of the skull  (Section 5.3.2). 
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6.3. Build-up calculation accuracy in megavoltage 
photon radiotherapy 
Accurate build-up dose calculations by the TPS are essential to the clinical 
management of both skin toxicity and superficial target coverage. Inaccurate 
build-up calculations might, for example, mislead IMRT or VMAT plan 
optimization when using superficial dose objectives or constraints. Build-up 
dose calculations, however, represent a complicated challenge. As for build-
up dose measurements, these complications relate to the presence of 
contaminating radiation, the lack of CPE and the steep dose gradient in the 
build-up region. 
 
Firstly, treatment planning systems need models of all radiation sources, 
accounting for variations in machine design and treatment parameters. To this 
purpose, most commercially available TPS use analytical representations of 
the radiation sources in the beam delivery system. In this dissertation, two 
algorithms were used: the analytical collapsed-cone convolution (CCC) 
algorithm implemented in Pinnacle (version 9.0, Philips Medical Systems) 
and the Monte Carlo-based XVMC code implemented in Monaco (version 
3.2., Elekta CMS Software). In the CCC algorithm in Pinnacle, the radiation 
leaving the linear accelerator head is described by a two-dimensional energy 
fluence array. Head scatter is accounted for by means of a head scatter source 
represented by a two-dimensional Gaussian. The energy fluence array is then 
adjusted based on the portion of the Gaussian visible from each point in the 
energy fluence plane. Following the photon dose computation, electron 
contamination is added using an exponential fall-off 32. The Monaco TPS, on 
the other hand, uses a virtual source model (VSM) including a primary 
                                                     
32 Pinnacle Physics Reference Guide, release 9, Philips Medical Systems (2009) 
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photon, scattered photon and electron contamination source, all represented 
by Gaussian functions 33. For both algorithms, input measurement data are 
used to fit the parameters of the analytical sources to each accelerator's 
specific characteristics. 
In our studies, considerable differences between build-up measurements 
and calculations were detected for both algorithms (Chapters 3, 4 and 5). In 
literature, such discrepancies are most frequently ascribed to the use of simple 
models for electron contamination in such virtual source-based algorithms 
(Van Esch et al., 2006; Panettieri et al., 2009). Accordingly, as the flattening 
filter was identified as the major source of electron contamination (Petti et 
al., 1983; Sjogren and Karlsson, 1996), removing the flattening filter is often 
suggested to enhance dose build-up calculation accuracy (Cashmore, 2008; 
Georg et al., 2011; Kragl et al., 2011). In our study, small calculation 
accuracy improvements were found for the unflattened compared to the 
flattened beam model. Such small improvements will, however, have limited 
clinical impact. Additionally, differences in calculation accuracy of this order 
of magnitude might result from small differences in tuning accuracy between 
the FF and FFF beam models. Importantly, considerable differences between 
build-up measurements and calculations persisted in both FF and FFF mode, 
emphasizing the importance of other factors that negatively affect build-up 
calculation accuracy. A major concern in this respect is the quality of the 
measurement data provided for beam modeling. These data are usually 
collected with small volume thimble ionization chambers, which are 
suboptimal for the very specific task of build-up dosimetry for multiple 
reasons. These reasons mainly include uncertainties in the effective point of 
measurement and volume averaging effects and are extensively discussed in 
                                                     
33 Monaco Dose Calculation Technical Reference, version 1.00, Elekta (2012) 
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Section 3.4. Considering these factors, specific build-up dosimetry techniques 
are mandatory for beam data collection. In this dissertation, parallel oriented 
radiochromic film has been identified as superior method for relative build-
up dosimetry. 
 
Secondly, build-up dose calculations also need to deal with the lack of CPE 
in the build-up region. The algorithms studied in this dissertation differ 
profoundly in this respect. The XVMC code simulates individual particle 
tracks (Fippel et al., 2003), while the CCC algorithm employs a kernel-based 
approach (Ahnesjo and Aspradakis, 1999). In this dissertation, build-up 
calculation accuracy was evaluated for both algorithms, but was not mutually 
compared. As the individual studies strongly differed with respect to 
treatment plan complexity and set-up, they do not allow a direct comparison 
of both algorithms. The CCC evaluation was, for example, performed using 
a human cadaver for more complex clinical treatment plans, while the XVMC 
calculations were mainly performed in polystyrene slab phantoms for single 
beams. 
 
The steep dose gradient of the build-up region represents a third important 
challenge to build-up dose calculations: accurate modeling of such steep 
gradients requires the use of small calculation grid sizes. Indeed, build-up 
calculation accuracy is reported to degrade with increasing grid sizes (Hsu et 
al., 2010; Panettieri et al., 2009). In our studies, the smallest possible grid size 
(1-1.5 mm) was systematically employed. For both treatment planning 
systems, the use of smaller grid sizes was either inherently inhibited or limited 
by the calculation time and memory available. In clinical practice, larger grid 
sizes are frequently used and might, as demonstrated in Chapter 5, result in 
the degradation of build-up calculation accuracy. 
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In this respect, it is equally important to note that even a dose grid resolution 
of 1 mm will not allow accurate calculation of the dose deposited in the most 
superficial tissues of interest, such as the basal cell layer (20-100 ?m depth, 
Section 1.2.1.). The estimation of the absorbed dose at these depths requires 
the use of specific techniques, such as described by De Wagter et al. (2015). 
The absorbed dose gradient between 115 and 254 ?m depth can be measured 
by two EBT2 radiochromic films, each with a different side facing the source. 
Extrapolation of this dose gradient to shallower depths allows for the 
estimation of absorbed doses between 20 and 100 ?m depth. 
In modern radiotherapy, treatment planning systems additionally need to deal 
with the increasing use of patient positioning devices (Olch et al., 2014). As 
mentioned in Section 6.2.2., avoiding beam incidences that intersect these 
devices is not always possible. Accurate modeling of dose perturbations is 
then highly recommended and requires TPS to account for attenuation of the 
focal and extrafocal radiation, as well as the attenuation and generation of 
particles within the device material. Additionally, incorporation of these 
devices into treatment planning requires accurate representation of the 
patient's set-up geometry with regard to the couch and positioning devices as 
well as excellent inter-fraction set-up reproducibility.  
To this purpose, two distinctive approaches have been employed in 
literature. A first approach is to manually contour the device components in 
the treatment planning system and artificially assign optimized densities to 
these contours (Mihaylov et al., 2008). A second methodology is to directly 
integrate the CT data of the device within the treatment planning CT (Gerig 
et al., 2010; Smith et al., 2010). In our studies, the latter approach allowed to 
precisely model the geometry of the AIO positioning device and its position 
with respect to the patient. Additionally, as the AIO solution is an indexed 
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positioning device, it also ensured optimal inter-fraction set-up 
reproducibility. Based on the device's CT data and a manual density override 
in the support cushions, the Monaco TPS was shown to accurately calculate 
the most important attenuation effects, but to fail accurate build-up dose 
prediction. Even though the algorithm did predict a build-up dose increase for 
beams traversing any of the investigated components, considerable 
discrepancies between measurements and calculations persisted. These 
calculation inaccuracies were the most pronounced for the 10 cm thick 
cushion foam for which an artificial electron density was assigned and 
optimized to match the measured versus calculated attenuation values, clearly 
illustrating that this approach does not adequately account for the attenuation 
and generation of particles within the cushion foam and coating. 
 
6.4. Build-up versus superficial dose 
While this dissertation focused on the important role of build-up doses in 
superficial dosimetry, it is important to note that build-up doses are not the 
only contributors to the superficially absorbed dose in megavoltage 
radiotherapy. 
 
Firstly, superficial doses are not only deposited by beams entering the tissue, 
but also by beams leaving the patient in this region. In breast-cancer patients 
treated with two opposed tangential fields, for example, the majority of the 
skin dose within the treatment field originates from exiting rather than 
entering beams (Cheung et al., 2002). In this respect, megavoltage photon 
beams also show a build-down effect in the last millimetres before exiting the 
patient, as there is no backscatter contributing to the absorbed dose. This 
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build-down effect is, however, much smaller compared to the build-up effect 
of megavoltage photon beams (Devic et al., 2006). 
 
Secondly, imaging procedures during treatment planning and delivery also 
contribute to superficial doses. These superficial imaging doses strongly 
depend on the imaging modality, imaging settings and anatomical region 
considered (Murphy et al., 2007). One widespread imaging procedure, for 
example, is kilovoltage cone-beam CT. For this technique, superficial doses 
of up to 7 cGy per acquisition have been reported in literature, although the 
values strongly differ depending on the CBCT system, protocol and 
anatomical region considered (Islam et al., 2006; Kan et al., 2008; Giaddui et 
al., 2013; Alaei et al., 2015).  
As a consequence, the relative contribution of image-guidance procedures 
to the total superficial dose in radiotherapy will strongly depend on both the 
imaging and treatment technique used, but should nevertheless not be 
neglected. For the IMRT breast cancer treatment described by Almberg et al. 
(2011) for example, the superficial doses reported by Giaddui et al. (2013) 
for one cone-beam CT scan with the standard XVI Chest M20 protocol 
correspond to approximately 5% to 11% of the superficial therapeutic doses 
delivered by one fraction of the hybrid IMRT and 7-field IMRT technique, 
respectively. A two-fold increase in superficial CBCT doses might occur for 
other CBCT systems, protocols or CBCT system releases used (Alaei et al., 
2015). 
In accordance with the ALARA (as low as reasonably achievable) 
principle generally employed in diagnostic imaging, reasonable effort should 
be made to minimize superficial imaging dose, especially when daily images 
are acquired (Murphy et al., 2007). Potential strategies in this respect include 
the use of a partial rotation, a reduction of the tube current or the use of a 
GENERAL  DISCUSSION,  FUTURE  PERSPECTIVES  AND  CONCLUSION 187 
 
smaller field-of-view (Islam et al., 2006). The impact of a partial rotation and 
a reduced tube current is discussed in De Puysseleyr et al. (2011) and De 
Puysseleyr et al. (2013) with respect to surface reconstruction, overall 
radiation exposure and clinical workflow. 
 
6.5. Future perspectives 
The build-up dose in megavoltage photon beams depends in a complex and 
non-intuitive manner on a variety of treatment parameters (Kry et al., 2012). 
Therefore, the monitoring of build-up doses will remain an important 
challenge for all future treatment technology evolutions affecting these 
parameters. Additionally, the increasing use of FFF linear accelerators and 
patient positioning devices (discussed in Chapter 3 and 4), requires future 
evaluation of the build-up doses during clinical implementation. For FFF 
linear accelerators, the effect of potential differences in treatment parameters 
between FF and FFF mode in clinical practice remains to be determined (see 
Section 6.2.1). For patient positioning devices, build-up dose perturbations 
will strongly depend on each device's geometry and composition and need to 
be assessed for all clinically implemented new devices. 
Additionally, the most critical factor to control and manage future evolutions 
of build-up dose in clinical practice is the TPS build-up calculation accuracy. 
Inaccuracies in build-up calculation, however, are regularly reported in 
literature (Chung et al., 2005; Higgins et al., 2007; Hsu et al., 2010) and in 
this dissertation, suggesting that TPS manufacturers need to be urged to invest 
in and collaborate on potential improvements of TPS calculation accuracy. 
One improvement, for example, might concern the use of an inhomogeneous 
dose grid facilitating a smaller dose grid in the steep dose gradient of the 
build-up region. Secondly, as discussed in Section 6.3, future improvements 
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in TPS calculation accuracy might be targeted at the introduction of more 
accurate build-up data during the beam modelling process, as these 
algorithms require input from or validation against reliable reference 
measurements. In this respect, our study identified radiochromic film as a 
valuable method for build-up data collection. 
6.6. Conclusions 
This dissertation investigated the impact of recent evolutions in treatment 
technology on the absorbed dose and calculation accuracy in the build-up 
region of megavoltage photon beams. 
In this respect, our results demonstrated radiochromic film to be a reliable 
build-up dose detector. For radiochromic film digitization in applications 
limited to small film sizes, the Nikon Coolscan 9000 ED transmission scanner 
was identified as the preferential tool compared to the widely used Epson 
Expression 10000XL flatbed scanner.  
Consequently, the absorbed dose in the build-up region of flattening filter-
free beams provided by standard linear accelerators was shown to slightly 
exceed build-up doses in conventional beams. The detected differences were, 
however, very small and might have limited clinical impact. Secondly, 
irradiating through the components of the AIO patient positioning device 
caused considerable and clinically relevant build-up dose increases. Thirdly, 
we demonstrated the potential of volumetric arc techniques to reduce the dose 
to the hair follicles by 20.5% on average compared to the standard lateral-
opposed fields technique. The associated hair loss score, however, was only 
reduced on the top and the back of the skull. 
Regarding calculation accuracy, considerable differences between build-
up measurements and calculations were detected for both investigated 
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algorithms. For the XVMC dose engine in the Monaco TPS, very small 
calculation accuracy improvements were found for the unflattened compared 
to the flattened beam model. Differences in calculation accuracy of this order 
of magnitude will, however, have limited clinical impact and might result 
from small differences in tuning accuracy between the FF and FFF beam 
models. 
Additionally, while the XVMC dose engine could accurately model the 
most important attenuation effects of the AIO patient positioning device, 
considerable build-up calculation inaccuracies were detected for beams 
traversing the AIO components. 
  
190 GENERAL  DISCUSSION,  FUTURE  PERSPECTIVES  AND  CONCLUSION 
References 
Abdel-Rahman W, Seuntjens J P, Verhaegen F, Deblois F and Podgorsak E 
B 2005 Validation of Monte Carlo calculated surface doses for 
megavoltage photon beams Med Phys 32 286-98 
Ahnesjo A and Aspradakis M M 1999 Dose calculations for external photon 
beams in radiotherapy Phys Med Biol 44 R99-R155 
Alaei P and Spezi E 2015 Imaging dose from cone beam computed 
tomography in radiation therapy Phys Medica 31 647-58 
Almberg S S, Lindmo T and Frengen J 2011 Superficial doses in breast cancer 
radiotherapy using conventional and IMRT techniques: A film-based 
phantom study Radiother Oncol 100 259-64 
Andreo P and Brahme A 1986 Stopping power data for high-energy photon 
beams Phys Med Biol 31 839-58 
Borca V C, Pasquino M, Russo G, Grosso P, Cante D, Sciacero P, Girelli G, 
La Porta M R and Tofani S 2013 Dosimetric characterization and use 
of GAFCHROMIC EBT3 film for IMRT dose verification Journal of 
Applied Clinical Medical Physics 14 158-71 
Butson M J, Yu P K N and 58 
Metcalfe P E 1999 Extrapolated surface dose measurements with 
radiochromic film Med Phys 26 485-8 
Cashmore J 2008 The characterization of unflattened photon beams from a 6 
MV linear accelerator Phys Med Biol 53 1933-46 
Cheung T, Butson M J and Yu P K N 2002 Multilayer Gafchromic film 
detectors for breast skin dose determination in vivo Phys Med Biol 
47 N31-N7 
Chiu-Tsao S T and Chan M F 2009 Photon beam dosimetry in the superficial 
buildup region using radiochromic EBT film stack Med Phys 36 
2074-83 
Chung H T, Jin H S, Dempsey J F, Liu C H, Palta J, Suh T S and Kim S Y 
2005 Evaluation of surface and build-up region dose for intensity-
modulated radiation therapy in head and neck cancer Med Phys 32 
2682-9 
De Puysseleyr A, Mulliez T, Gulyban A, Bogaert E, Vercauteren T, Van Hoof 
T, Van de Velde J, Van Den Broecke R, De Wagter C and De Neve 
W 2013 Improved cone-beam computed tomography in supine and 
prone breast radiotherapy. Surface reconstruction, radiation 
exposure, and clinical workflow Strahlenther Onkol 189 945-50 
De Puysseleyr A, Veldeman L, Bogaert E, De Wagter C and De Neve W 2011 
Optimizing image acquisition settings for cone-beam computed 
GENERAL  DISCUSSION,  FUTURE  PERSPECTIVES  AND  CONCLUSION 191 
 
tomography in supine and prone breast radiotherapy Radiother Oncol 
100 227-30 
Devic S, Seuntjens J, Hegyi G and Podgorsak E B 2004 Dosimetric properties 
of improved GafChromic films for seven different digitizers Med 
Phys 31 2392-401 
Devic S, Seuntjens J, Abdel-Rahman W, Evans M, Olivares M, Podgorsak E 
B, Vuong T and Soares C G 2006 Accurate skin dose measurements 
using radiochromic film in clinical applications Med Phys 33 1116-
24 
De Wagter C, De Maeseneire N, Goethals N, De Puysseleyr A, De Neve W 
and Lievens Y 2015 PO-0847: Exploiting the asymmetric layer 
geometry of EBT2 radiochromic film for assessment of skin dose and 
steep gradients Radiotherapy and Oncology 115 S429 - S430 
Fippel M, Haryanto F, Dohm O, Nusslin F and Kriesen S 2003 A virtual 
photon energy fluence model for Monte Carlo dose calculation Med 
Phys 30 301-11 
Georg D, Knoos T and McClean B 2011 Current status and future perspective 
of flattening filter free photon beams Med Phys 38 1280-93 
Gerig L H, Niedbala M and Nyiri B J 2010 Dose perturbations by two carbon 
fiber treatment couches and the ability of a commercial treatment 
planning system to predict these effects Med Phys 37 322-8 
Giaddui T, Cui Y, Galvin J, Yu Y and Xiao Y 2013 Comparative dose 
evaluations between XVI and OBI cone beam CT systems using 
Gafchromic XRQA2 film and nanoDot optical stimulated 
luminescence dosimeters Med Phys 40 062102 (12pp.) 
Higgins P D, Han E Y, Yuan J L, Hui S and Lee C K 2007 Evaluation of 
surface and superficial dose for head and neck treatments using 
conventional or intensity-modulated techniques Phys Med Biol 52 
1135-46 
Hsu S H, Moran J M, Chen Y, Kulasekere R and Roberson P L 2010 Dose 
discrepancies in the buildup region and their impact on dose 
calculations for IMRT fields Med Phys 37 2043-53 
Islam M K, Purdie T G, Norrlinger B D, Alasti H, Moseley D J, Sharpe M B, 
Siewerdsen J H and Jaffray D A 2006 Patient dose from kilovoltage 
cone beam computed tomography imaging in radiation therapy Med 
Phys 33 1573-82 
Javedan K, Feygelman V, Zhang R R, Moros E G, Correa C R, Trotti A, Li 
W and Zhang G G 2014 Monte Carlo comparison of superficial dose 
between flattening filter free and flattened beams Phys Medica 30 
503-8 
192 GENERAL  DISCUSSION,  FUTURE  PERSPECTIVES  AND  CONCLUSION 
Kan M W K, Phil M, Leung L H T, Wong W W and Lam N 2008 Radiation 
dose from cone beam computed tomography for image-guided 
radiation therapy Int J Radiation Oncology Biol Phys 70 272-279 
Kragl G, Albrich D and Georg D 2011 Radiation therapy with unflattened 
photon beams: Dosimetric accuracy of advanced dose calculation 
algorithms Radiother Oncol 100 417-23 
Kry S F, Smith S A, Weathers R and Stovall M 2012 Skin dose during 
radiotherapy: a summary and general estimation technique J Appl 
Clin Med Phys 13 3734 
Mihaylov I B, Corry P, Yan Y, Ratanatharathorn V and Moros E G 2008 
Modeling of carbon fiber couch attenuation properties with a 
commercial treatment planning system Med Phys 35 4982-8 
Murphy M J, Balter J, Balter S, BenComo J A, Jr., Das I J, Jiang S B, Ma C 
M, Olivera G H, Rodebaugh R F, Ruchala K J, Shirato H and Yin F 
F 2007 The management of imaging dose during image-guided 
radiotherapy: report of the AAPM Task Group 75 Med Phys 34 4041-
63 
Olch A J, Gerig L, Li H, Mihaylov I and Morgan A 2014 Dosimetric effects 
caused by couch tops and immobilization devices: report of AAPM 
Task Group 176 Med Phys 41 061501 
Paelinck L, De Wagter C, Van Esch A, Duthoy W, Depuydt T and De Neve 
W 2005 Comparison of build-up dose between Elekta and Varian 
linear accelerators for high-energy photon beams using radiochromic 
film and clinical implications for IMRT head and neck treatments 
Phys Med Biol 50 413-28 
Panettieri V, Barsoum P, Westermark M, Brualla L and Lax I 2009 AAA and 
PBC calculation accuracy in the surface build-up region in tangential 
beam treatments. Phantom and breast case study with the Monte 
Carlo code PENELOPE Radiother Oncol 93 94-101 
Petti P L, Goodman M S, Sisterson J M, Biggs P J, Gabriel T A and Mohan 
R 1983 Sources of Electron Contamination for the Clinac-35 25-Mv 
Photon-Beam Med Phys 10 856-61 
Sjogren R and Karlsson M 1996 Electron contamination in clinical high 
energy photon beams Med Phys 23 1873-81 
Smith D W, Christophides D, Dean C, Naisbit M, Mason J and Morgan A 
2010 Dosimetric characterization of the iBEAM evo carbon fiber 
couch for radiotherapy Med Phys 37 3595-606 
Sorriaux J, Kacperek A, Rossomme S, Lee J A, Bertrand D, Vynckier S and 
Sterpin E 2013 Evaluation of Gafchromic (R) EBT3 films 
characteristics in therapy photon, electron and proton beams Physica 
Medica-European Journal of Medical Physics 29 599-606 
GENERAL  DISCUSSION,  FUTURE  PERSPECTIVES  AND  CONCLUSION 193 
 
Suchowerska N, Hoban P, Butson M, Davison A and Metcalfe P 2001 
Directional dependence in film dosimetry: radiographic and 
radiochromic film Phys Med Biol 46 1391-7 
Van Esch A, Tillikainen L, Pyykkonen J, Tenhunen M, Helminen H, 
Siljamaki S, Alakuijala J, Paiusco M, Iori M and Huyskens D P 2006 
Testing of the analytical anisotropic algorithm for photon dose 
calculation Med Phys 33 4130-48 
Wang Y N, Khan M K, Ting J Y and Easterling S B 2012 Surface Dose 
Investigation of the Flattening Filter-Free Photon Beams Int J Radiat 
Oncol 83 E281-E5 
Yu P K, Butson M and Cheung T 2006 Does mechanical pressure on 
radiochromic film affect optical absorption and dosimetry? Australas 
Phys Eng Sci Med 29 285-7 
 
  

  
 
 
 
Publication List 
  
  
 
  
  
De Puysseleyr A, Mulliez T, Gulyban A, Bogaert E, Vercauteren T, Van Hoof 
T, Van de Velde J, Van Den Broecke R, De Wagter C and De Neve 
W 2013 Improved cone-beam computed tomography in supine and 
prone breast radiotherapy. Surface reconstruction, radiation 
exposure, and clinical workflow Strahlenther Onkol 189 945-50 
 
De Puysseleyr A, Srivastava R P, Paelinck L, De Neve W and De Wagter C 
2012 Evaluation of a glassless photographic film scanner for high-
gradient radiochromic film dosimetry Phys Med Biol 57 127-42 
 
De Puysseleyr A, Van De Velde J, Speleers B, Vercauteren T, Goedgebeur 
A, Van Hoof T, Boterberg T, De Neve W, De Wagter C and Ost P 
2014 Hair-sparing whole brain radiotherapy with volumetric arc 
therapy in patients treated for brain metastases: dosimetric and 
clinical results of a phase II trial Radiat Oncol 9 170 
 
De Puysseleyr A, Veldeman L, Bogaert E, De Wagter C and De Neve W 2011 
Optimizing image acquisition settings for cone-beam computed 
tomography in supine and prone breast radiotherapy Radiother Oncol 
100 227-30 
 
Srivastava R P, De Puysseleyr A and De Wagter C 2012 Skin dose assessment 
in unmodulated and intensity-modulated radiation fields with film 
dosimetry Radiat Meas 47 504-11 
 
De Puysseleyr A, De Neve W and De Wagter C,  A patient immobilization 
device for prone breast radiotherapy: dosimetric effects and 
inclusion in the treatment planning system, Submitted to: Physica 
Medica 
 
De Puysseleyr A, Lechner W, De Neve W, Georg D and De Wagter C, 
Absorbed dose measurements and calculation accuracy in the build-
up region of flattened versus unflattened megavoltage photon beams, 
Submitted to: Zeitschrift für Medizinische Physik 
  

  
 
 
 
Dankwoord 
  

  
De voorbije jaren heb ik met veel plezier aan mijn doctoraat gewerkt, daarom 
een speciaal woord van dank aan iedereen die daar op zijn manier aan heeft 
bijgedragen.  
 
Mijn grootste dank gaat uit naar mijn promotor, Prof. Dr. Ir. De Wagter. 
Professor, er zijn ontelbare manieren waarop ik dit proefschrift aan u te 
danken heb. Bedankt voor alle kansen, uw geduld en steun. Ik vind het een 
eer dat u mijn promotor bent en hou er warme herinneringen aan over.  
Ook mijn copromotor Prof. Dr. De Neve wil ik bedanken voor de kans om 
wetenschappelijk onderzoek te verrichten en voor de talrijke klinische stimuli 
en feedback.  
 
Ook de dienst Radiotherapie van het Universitair Ziekenhuis Gent en de 
Vakgroep Radiotherapie en Experimenteel Kankeronderzoek van de 
Universiteit Gent wil ik bedanken om dit wetenschappelijk onderzoek 
mogelijk te maken. Dank ook aan mijn sponsors, het Fonds voor 
Wetenschappelijk Onderzoek (FWO) en het Nationaal Kankerplan, een 
initiatief van minister Laurette Onkelinx. 
 
Bedankt ook aan alle leden van de examencommissie om mijn proefschrift 
kritisch te evalueren. Uw waardevolle feedback heeft de kwaliteit van het 
manuscript sterk verbeterd.  
 
Daarnaast wil ik in het bijzonder alle stralingsfysici van de dienst 
Radiotherapie bedanken voor de vele hulp. Dank ook aan alle artsen en 
planners voor de klinische uitleg, en aan alle verpleegkundigen voor de 
praktische organisatie voor de metingen. Bedankt ook Bart en Sam voor de 
vele fantomen en opstellingen die jullie maakten. 
  
Een speciaal woord van dank verdienen ook mijn co-auteurs, in het bijzonder 
bij de kadaverstudie, voor de aangename samenwerking en de hulp bij het 
schrijven van de publicaties.  
I would also like to thank Dr. Wolfgang Lechner and Prof. Dietmar Georg 
from the Medical University of Vienna, for your collaboration and the warm 
welcome in your research group during my stay in Vienna.  
 
Ook mijn mede-doctoraatsstudenten - Raju, Nathan en Stéphanie- wil ik 
bedanken. Bedankt voor jullie enthousiasme en de aangename 
werkomgeving. Leen, bedankt om me op weg te helpen met filmdosimetrie 
en voor alle steun.  
 
Een laatste bijzonder woord van dank gaat uit naar mijn familie. Mama en 
Papa, ik kan niet beschrijven hoe dankbaar ik jullie ben. Jullie steun en 
warmte zorgen nog elke dag dat ik vol vertrouwen op weg kan. Bedankt dat 
jullie er altijd voor mij zijn!  
Dankjewel ook Zusjes, jullie gaven mij alledrie het goede voorbeeld, niet 
alleen wat doctoreren betreft. Leentje en Kristien, bedankt dat jullie altijd 
klaar staan, in het bijzonder bij de laatste loodjes.  
Tot slot, lieve Kim, dankjewel om er altijd te zijn voor mij. Je zag voor 
mij de bomen door het bos, ik heb zoveel geluk dat ik jou elke dag bij mij 
mag hebben. 
 
  

